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Many signal transduction pathways in eukaryotic cells are controlled by the reversible
assembly of proteins into signalling complexes that integrate and transmit signals from
cell surface receptors to the cytoplasm and nucleus. Protein phosphorylation on serine,
threonine and tyrosine residues plays a key role in these events by creating binding sites
for modular protein-interaction domains to allow proteins to associate with one another,
and regulating the activitiy ofmany enzymes and transcription factors.
The extracellular signal regulated kinase (ERK) cascade is one of the most intensively
studied signalling pathways in mammalian cells. ERK 1 and 2 have been shown to
regulate gene expression programmes in response to extracellular signals, including
gonadotrophin releasing hormone (GnRH), which binds to a G-protein coupled receptor
(GPCR). However, many questions remain to be answered regarding the proximal events
that lead to the activation of the ERK cascade by GnRH.
A HEK 293 cell line, stably expressing the rat GnRH receptor, was used to investigate
the mechanism of ERK activation by GnRH. ERK activation was found to be dependent
on cell adhesion to the extracellular matrix, and required an intact actin cytoskeleton.
Through the use of specific pharmacological inhibitors and by expression of dominant
negative cDNA constructs, ERK activation was found to be mediated by the Rho family
GTPase Racl, and the non-receptor tyrosine kinases focal adhesion kinase (FAK) and
Src. FAK was found to function as a tyrosine phosphorylated scaffold upon which key
components of the ERK cascade assembled.
Having established a role for Src in the activation of ERK, a proteomics study was
undertaken to identify novel Src binding proteins that may be involved in the regulation
of GnRH receptor signalling. Through a combination of immune precipitation, two-
dimensional gel electrophoresis and matrix assisted laser desorption ionisation-time of
flight (MALDI-ToF) mass spectrometry, Src was found to associate with the lipid kinase
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diacylglycerol kinase t, (DGKQ. This interaction was found to be required for GnRH to
stimulate DGK^ enzyme activity. By phosphorylating the second messenger molecule
diacylglycerol to produce phosphatidic acid, DGK^ may play an important role in
regulating GnRH receptor signalling.
In this thesis, a potential mechanism of ERK activation is described for the GnRH
receptor, with Src playing a key role in this pathway. In addition, Src was found to be
involved in the activation of DGK^, and is therefore implicated in the regulation of




This literature review is divided into two parts. In the first part, modular protein- and
lipid-interaction domains are introduced, and their role in controlling the activity and
substrate specificity of protein kinases are discussed. Src and the conventional and novel
protein kinase C (PKC) isozymes are given as examples. In the second part,
Gonadotrophin releasing hormone (GnRH) physiology is introduced and GnRH receptor
signalling discussed. Emphasis is placed on the role of interaction domains and protein
kinases in this process.
Signal transduction in eukaryotic cells
Virtually every aspect of cellular function within a metazoan organism is controlled by
external signalling molecules, either in the form of soluble hormones or proteins
anchored to the membrane of adjacent cells or the extracellular matrix. These factors
exert their effects by binding to receptors on the surface of the cell and activating a
myriad of intracellular signal transduction pathways. Over the past two decades,
considerable advances have been made in the field of signal transduction and have
demonstrated that many signalling pathways in eukaryotic cells are regulated by the
reversible assembly of protein complexes, which integrate and transmit signals from
receptors to the cytoplasm and nucleus (Pawson and Scott, 1997).
Many proteins involved in intracellular signalling are constructed in a modular fashion
from domains that have enzyme activity or mediate molecular interactions. These
interaction domains target proteins to specific subcellular localisations, provide a means
for recognition of post-translational modifications or chemical second messengers,
nucleate the formation of signalling complexes, and control the conformation, activity,
and substrate specificity ofmany enzymes (Pawson and Nash, 2003). Thus, they assist in
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maintaining the fidelity of signal transduction. As a result mutations in these domains
contribute to a number of pathological conditions, including cancer (Tartaglia et al.,
2001; He et al., 2002).
Modular interaction domains
Modular interaction domains often fold independently with their N- and C-termini
closely apposed in space, allowing them to be readily incorporated into proteins in a
manner that leaves their ligand-binding surface available (Pawson and Nash, 2003). This
feature is thought to have facilitated the evolution of complex signalling pathways in
eukaryotic cells, as they can be incorporated into proteins to create new connections and
bestow new functions. Indeed, several interaction domains are present in hundreds of
copies in the genome of mammals (Venter et al., 2001). Evolution therefore appears to
have used a limited set of domains, joined together in a combinatorial fashion, to direct
the actions ofmany enzymes (Pawson and Scott, 1997; Pawson and Nash, 2003).
Modular interaction domains can usually be identified through their consensus amino
acid sequences, allowing the binding properties of proteins to be predicted (Copley et al.,
2002). They recognise exposed sites on their protein partners or bind the charged head
groups of phospholipids, with dissociation constants in the low nanomolar to high
micromolar range. Typically, a protein-interaction domain recognises a core determinant
with flanking residues providing additional contacts and an element of specificity
(Songyang et al., 1993; Gustafson et al., 1995). Post-translational modifications often
complete binding sites, allowing precise control of ligand binding, enzyme activity, and
the assembly of signalling complexes. The most frequently used modification is the
phosphorylation of serine, threonine or tyrosine residues. However, hydroxylation,
acetylation, methylation, ubiquitination and sumoylation of proteins can also function to
control modular interactions (Min et al., 2002; Jacobson et al., 2000; Bannister et al.,
2001; Polo et al., 2002, Melchior, 2000). hi many cases, the affinity of a single domain
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for a peptide motif appears sufficient for a specific interaction to occur between two
proteins in vitro. However, tertiary interactions, sub-cellular localisation and structural
organisation of interacting proteins are also likely to contribute to selectivity in vivo
(Pawson and Nash, 2003).
In the following discussion emphasis is placed on Src homology 2 (SH2), Src homology
3 (SH3), C kinase homology 1 (CI) and C kinase homology 2 (C2) domains, which
regulate the activity of many enzymes and are therefore important modulators of signal
transduction. SH2 and SH3 domains were among the first protein-interaction modules to
be described, and have been shown to recognise phosphotyrosine motifs and proline rich
sequences in their protein partners, respectively (Anderson et al., 1990; Ren et al., 1993).
They are frequently found together in the non-receptor tyrosine kinases, where they
regulate the activity of the catalytic domain and its interaction with target molecules
(Pellicena et al., 1998; Schaller et al., 1999). CI and C2 domains were first identified in
conventional and novel PKC isozymes, and were found to bind diaclglycerol and
phosphatidylserine, respectively (Newton, 1997). Subsequently, they have been identified
in a wide range of cytoplasmic proteins and additional ligands have been discovered.
Numerous structural and biochemical studies have provided many details of the
mechanisms of ligand binding for these important domains.
SH2 domains
The SH2 domain was originally defined in the retroviral oncoprotein v-Fps as a sequence
of approximately 100 amino acids that regulated the function of the catalytic domain and
its interaction with target proteins in the host cell (Sadowski et al., 1986). Related
sequences were identified in Src family kinases, leading to the 'Src homology domain'
nomenclature, with the catalytic domain designated SHI. Subsequently, SH2 domains
were identified in many proteins involved in signal transduction and were found to bind
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phosphotyrosine motifs in receptor tyrosine kinases and cytoplasmic proteins alike
(Anderson et ah, 1990; Mayer et ah, 1991).
The SH2 fold (Figure 1) consists of a seven-stranded (3-meander that is sandwiched on
either side by an a-helix (Waksman et ah, 1992). The spine of the domain comprises an
anti-parallel P-sheet formed from strands PA, PB, PC, PD and PG, which divide it into
two functionally distinct sides. One side, flanked by helix aA, binds the phosphotyrosine
moiety, while the other side, flanked by helix aB and the EF and BG loops, provides
residues that interact with the side chains of the peptide ligand C-terminal to the
phosphotyrosine (Waksman et ah, 1992; Kuriyan and Cowbum, 1997). In most SH2-
ligand structures, the phosphopeptide binds in an extended conformation and lies across
the surface of the domain perpendicular to the axis of the central p-sheet. The SH2-ligand
interaction is of moderate strength (Kd ~ 0.1 pM - 1.0 pM) and analyses of binding
kinetics have shown that the on and off rates are quite high, allowing rapid association
and dissociation of the ligand (Felder et ah, 1993). This feature is common to a number
of interaction domains that recognise phosphorylated motifs and may therefore be
physiologically important given the transient nature of many signal transduction events,
as the balance shifts between the activity of protein kinases and phosphatases (Yaffe and
Elia, 2001; Pawson and Nash, 2003).
Although the specifics of ligand binding vary between individual SH2 domains, the
overall nature of the interaction is well conserved. Phosphotyrosine recognition elements
are provided by residues in aA, PB, pD, and the loop connecting strands PB and pC. The
phosphotyrosine sits in a moderately deep pocket; the backbone of the residue is held in
position by residues in the pD strand, and the phosphate group enters into ionic
interactions with ArgPB5 (Waksman et ah, 1992; Kuriyan and Cowburn, 1997). This
interaction is strictly conserved in all SH2 domains, and mutation of the arginine residue
to alanine significantly inhibits ligand binding (Mayer et ah, 1992). The location of
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PB5
Fps WYH GAI PRSEVQELLK CS G DFLVRES QGKQ EYVLSVLW D
Src WYF GKI TRRESERLLL NPENPR G TFLVRES ETTK G AYCLSVSD FD
Hck WFF KGI SRKDAERQLL APGNML G SFMIRDS ETTK G STSLSVRD YD
Lck WFF KNL SRKDAERQLL APGNTH G SFLIRES ESTA G SFSLSVRD FD
Grb2 WFF GKI PRAKAEEMLS GQRHD G AFLIRES ESAP G DFSLSVKF
She WFH GKL SRREAEALLQ LN G DFLVRES TTTP G QYVLTGLQ R
PA aAl pB pc
Fps G QRPHFII QAA DN LYRL EG DGF S TIPLLIDHLLQS
Src NAK GL NVKHYKI RKL DS G GFYI TSR TQF S SLQQLVAYYSKH
Hck PRQ GD TVKHYKI RTL DN G GFYI SPR STF S TLQELVDHYKKG
Lck QNQ GE WKHYKI RNL DN G GFYI SPR ITF P GLHDLVRHYTNA
Grb2 GN DVQHFKV LRD GA G KYFL WV VKF N SLNELVDYHRST
She G QPKHLLL VDP E G WRT KD HRF E SVSHLISYHMDN
PD PD' pE pF cxA2
Fps QQPIT KK SGI NLR KPC
Src ADGL CH RLT NVC
Hck NDGL CQ KLS VPC
Lck SDGL CT RLS RPC
Grb2 SVSRN QQI FLR DIE
She HLPIIS AGSEL CLQ QPV
PG
Figure 1: Sequence alignment of SH2 domains. Several SH2 domains from non-receptor
tyrosine kinases and adapter proteins are shown, red and blue boxes indicate the positions of a-
helices and P-strands, respectively. The conserved arginine residues at the PB5 position, which
plays a critical role in phosphotyrosine recognition, is highlighted in bold. Adapted from Kuriyan
and Cowburn (1997).
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ArgPB5 is such that in the fully extended conformation, its side chain is just long enough
to interact with the phosphate group of the ligand. The ArgPB5 side chain rises up to
meet the phosphate from the interior of the domain, and in the crystal structures of Src
and Lck SH2 domains it is not solvent accessible in this complex (Kuriyan and Cowbum,
1997). Under these circumstances, formation of the optimal ionic interactions is critical
for phosphate recognition, thus phosphoserine or phosphothreonine are not bound.
Several side chains and backbone groups satisfy the hydrogen bonding potential of the
phosphate group and provide hydrophobic interactions with the aromatic ring of the
phosphotyrosine. However, the nature of these interactions varies with individual SH2
domains. In the case of the SH2 domains of the Src family kinases, there is an amino-
aromatic interaction between ArgaA2 and the phenol ring of the phosphotyrosine
(Waksman et al., 1992; Tong et al., 1996). Such interactions have been observed in a
number of protein structures and can provide stabilisation comparable to that of a
hydrogen bond (Burley and Petsko, 1986). It has been suggested that this type of
interaction is favourable when conventional hydrogen bonding is not possible.
Phosphotyrosine binding provides approximately half of the binding free energy that is
seen with specific phosphopeptides (Bradshaw et al., 1999). The large energetic
contribution of the phosphotyrosine residue to ligand binding therefore strongly
discriminates between phosphorylated and non-phosphorylated sequences. The remaining
free binding energy comes from a network of interactions involving adjacent residues
(Bradshaw and Waksman, 1999). Using phosphopeptide libraries, many SH2 binding
specificities have been identified (Cantley and Songyang, 1994). This pioneering work
established that the three residues immediately C-terminal to the phosphotyrosine are key
determinants of specificity, and that sequence preferences in the targets could be
correlated with particular residues in the SH2 domain. The clearest example of this
correlation is provided for by the residue at the (3D5 position, which contacts the side
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chains of the ligand at the pY+1 and pY+3 positions. The SH2 domains of the Src family
kinases have aromatic side chains at pD5 and preferentially bind peptides containing
polar side chains at the pY+1 position. In contrast, the SH2 domains of PLCy have
hydrophobic residues at 0D5 and preferentially select hydrophobic amino acids at the
pY+1 position (Cantley and Songyang, 1994). Furthermore, by mutating this critical
amino acid, it is often possible to switch the binding specificity of individual SH2
domains (Marengere et al., 1994; Songyang et al., 1995a).
Because SH2 domains play an important role in controlling protein interactions,
mutations in them have been implicated in a number of pathological conditions. For
example, point mutations in the SH2 domain of Bruton's tyrosine kinase cause some
cases of X-linked agammaglobulinaemia (Vihinen et al., 1999). These mutant proteins
cannot interact with their tyrosine phosphorylated substrates during B cell development
(Mattson et al., 2000), resulting in severe B cell deficiency due to the failure of precursor
cells to differentiate in the bone marrow (Noordzij et al., 2002). Point mutations in the
SH2 domain of SAP, a T-cell specific adapter protein that mediates signalling through the
SLAM receptor (Latour et al., 2001), cause X-linked lymphohyperproliferative
syndrome, which is characterised by impaired cytotoxic activities of T cells (Sharifi et
al., 2004) and extreme susceptibility to infection by Epstein-Barr virus (Purtilo et al.,
1975). These studies emphasise the important role played by SH2 domains in maintaining
the fidelity of signal transduction pathways involving the tyrosine phosphorylation of
proteins, and in the physiology of the whole organism.
SH3 domains
SH3 domains are small (55 - 70 amino acid) protein-interaction modules that are found
in many signalling proteins (Pawson, 1995). In addition, they are also present in a
number of proteins involved in the regulation of the cytoskeleton, and may therefore
represent a link between signal transduction pathways and the structural organisation of
22
the cell (Musacchio et al., 1992a). The SH3 fold (Figure 2) is highly conserved and
consists of a two-stranded P-sheet and a three-stranded P-sheet packed together
approximately at right angles to form a P-barrel structure (Musacchio et al., 1992b). The
inner face of the P-sheets form a hydrophobic core lined with conserved aromatic
residues, which maintain the structure of the binding site and make contacts with the
peptide ligand (Yu et al., 1992). Determination of SH3-ligand structures by X-ray
crystallography established that the ligand forms a left-handed type II polyproline helix
(Musacchio et al., 1994). Polypeptides with this conformation adopt an extended
molecular scaffold that is well suited to the long shallow groove of the SH3 domain (Yu
et al., 1994). In comparison, an a-helix with an equivalent number of residues would be
approximately half the length. However, the most striking feature of the polyproline type
II helix is its highly regular structure and approximately three-fold symmetry. The helix
has three residues per turn and amino acids at position n and n+3 lie on the same face of
the helix (Adzhubei and Sternberg, 1993).
Polyproline type II helices are ideal mediators of protein-protein interactions as they are
frequently found on the surface of globular proteins (Adzhubei and Sternberg, 1993).
This is because the structure is not internally hydrogen bonded but depends on backbone
solvation for stability (Adzhubei and Sternberg, 1993). The bound peptide interacts with
the SH3 domain by intercalating its side chains into the ladder of aromatic residues that
line the binding site (Feng et al., 1994). Screening combinatorial libraries of proline rich
peptides has identified optimal ligands for a number of SH3 domains (Yu et al., 1994).
Optimal ligands for the SH3 domain of PI-3 kinase have the consensus sequence
R-X-L-P-P-R-P-X-X, where X represents any amino acid other than cysteine, while
ligands for the SH3 domain of Src have a similar consensus sequence,
R-X-L-P-P-L-P-R-<)>, where X represents any amino acid other than cysteine and <j>
represents a hydrophobic residue.
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Sem5 EAVA EHDF QAGSPD ELSFKRGN TLKVLN KDEDPH WYKAEL D GN
Src TFVA LYDY ESRTET DLSFKKGE RLQIVN NTE GD WWLAHS LSTGQ
Hck IWA LYDY EAIHHE DLSFQKGD QMWLE ES GE WWKARS LATRK
Fyn LFVA LYDY EARTED DLSFHKGE KFQILN SSE GD WWEARS LTTGE
Nck2 PAVY KFNY MAERED ELSLIKGT KVIVME KCS DG WWRGSY N GQ
N WMafy
PA PB PC
Sem5 EGFI PSNY IRM TE
Src TGYI PSNY VAP SD
Hck EGYI PSNY VAR VD
Fyn TGYI PSNY VAP VD
Nck2 VGWF PSNY VTE EG
■4 ^ C
PD pE
Figure 2: Sequence alignment of SH3 domains. The SH3 domains from several non-receptor
tyrosine kinases and adapter proteins are shown, blue boxes indicate the position of P-strands.
Adapted from Kuriyan and Cowburn (1997).
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Comparison of the sequences of many SH3 binding motifs revealed they contain a
conserved P-X-X-P motif (Yu et al., 1994). However, most ligands contain more than
two proline residues. The occurrence of multiple prolines within the ligand may be
favourable because the pyrrolidone rings restrict the conformation of the polypeptide,
thereby promoting the left handed type II helix conformation (Yu et al., 1994). In
particular, additional proline residues are commonly found in the P-2 and P+l positions,
where P represents the first amino acid of the conserved P-X-X-P motif. These residues
are especially suitable for substitution because they point away from the binding surface
of the SH3 domain in the SH3-ligand complex and do not mediate specific contacts.
Rather, proline residues at these sites appear to facilitate SH3 binding by helping to
stabilise the conformation of the ligand and induce the proper spacing and orientation of
key contact residues (Yu et al., 1994). Other amino acids at these positions tend to be
hydrophobic, possibly reflecting packing interactions between the helix and the rest of the
SH3 binding protein (Yu et al., 1994). An unusual feature of the SH3 domain is that
ligands appear to be able to bind in two orientations (Yu et al., 1994; Feng et al., 1994).
The direction in which the peptide binds is determined primarily by charge pairing
between arginine residues in the peptide and acidic residues on the surface of the domain
(Lim et al., 1994).
Because SH3 domains bind to their targets with a relatively small interaction surface,
with limited hydrogen bonding, SH3-ligand interactions tend to be quite weak (Kd ~ 1
- 10 pM). The reliance of binding affinity on hydrophobic interactions, which are
generally less specific than those involving hydrogen bond formation, also results in
relatively promiscuous peptide recognition. Therefore, for many SH3 domains,
specificity requires multiple binding sites and/or tertiary interactions. For example, in
many of the non-receptor tyrosine kinases, SH3 domains compliment SH2 domains in
target recognition, and thereby function to increase the affinity of the kinase for its
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substrates. As a result, mutations in SH3 domains can contribute to a number of
pathological conditions. For example, deletion of the C-terminal 21 amino acids of
the SH3 domain of Bruton's tyrosine kinase causes some cases of X-linked
lymphohypoproliferative syndrome (Zhu et al., 1994). The deletion of these amino
acids causes the domain to adopt a random coil conformation rather than the normal
P-barrel structure (Chen et al., 1996), which prevents it form binding its cognate
ligands.
CI domain
CI domains are small (approximately 50 amino acid) lipid-interaction modules that are
found in many proteins involved in cell signalling, notably the PKCs, diacylglycerol
kinases (DGKs), kinase supressor of Ras (KSR) and Raf-1. They contain the conserved
sequence motif H-X10-12-C-X2-C-Xn-19-C-X2-C-X4-H-X2.4-C-X5.9-C (Zhou et al., 2002)
that is responsible for co-ordinating two Zn2+ ions that are required for the proper folding
of the domain (Quest et al., 1992). The CI domain (Figure 3) belongs to the zinc finger
fold, and consists of two small P-sheets and a very short C-terminal a-helix. The first P-
sheet is formed from strands pi, P4 and p5, and the second from strands P2 and P3. The
C-terminal helix packs against the pi strand to fonn one of the Zn2+ binding sites, while
the other is formed from residues in the loop connecting strand P5 and the C-terminal
helix (Mott et al., 1996; Zhou et al., 2002). The two histidine residues and five of the
conserved cysteine residues are absolutely required for the co-ordination of the Zn2+ ions,
and mutation of any of these residues has a detrimental effect on the structural integrity of
the domain and consequently inhibits ligand binding (Kazanietz et al., 1995).
Biochemical and mutational studies have shown that CI domains bind to membranes via
a combination of electrostatic and hydrophobic interactions. Basic residues around the
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PKCa HKFKIHTY GSP TFC DHCG SLL YGLIHQG MKC DTCD MNV HKQ
PKCS HRFKVYNY MSP TFC DHCG TLL WGLVKQG LKC EDCG MNV HHK






Figure 3: Sequence alignment of CI domains. The CI domains of PKCa, PKCS and Raf-1 are
shown. Red and blue boxes indicate the positions of a-helices and p-strands, respectively. The six
conserved cysteine residues and the two conserved histidine residues are highlighted in bold.
Adapted from Zhang et al. (1995) and Mott et al. (1996).
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top of the domain make electrostatic contacts with the head groups of acidic
phospholipids such as phosphatidylserine, while the side chains of hydrophobic residues
in the pi-(32 and p3-p4 loops penetrate into the membrane (Bittova et al., 2001; Zhou et
al., 2002). Differences in the amino acid sequence of these loops are thought to determine
the lipid binding specificity of individual CI domains (Mott et al., 1996; Zhou et al.,
2002), though this remains to be fully investigated.
Because CI domains play a crucial role in regulating the activation and subcellular
localisation of several important enzymes, mutations associated with them contribute to a
number of pathological conditions. For example, missense mutations in the CI domains
of PKCy cause some cases of spinocerebellar ataxia, a severe and debilitating hereditary
neurodegenerative disorder that is characterised by progressive loss of gait and motor
function, and by speech and eye movement disturbances (Chen et al., 2003). However,
only neurones in the central nervous system are affected in this disorder, due to the
restricted tissue distribution of PKCy.
C2 domain
C2 domains are a second class of lipid-interaction modules that are found in many
proteins involved in cell signalling, including the PKCs, phospholipase Cs (PLCs),
phospholipase A2 (PLA2), and the synaptotagmins. The C2 fold consists of a compact
anti-parallel (1-sandwich composed of eight P-strands connected by three loops at the top
of the domain and four loops at the bottom (Sutton et al., 1995; Essen et al., 1996; Shao
et al., 1996). There is a high degree of structural homology between C2 domains in their
core P-sandwiches, however, the sequences of the top loops, which are involved in ligand
binding, are much more variable (Rizo and Siidhof, 1998).
Classically, the C2 domains have been divided into two groups based on their mode of
ligand binding. The first group, which includes the C2 domains of the conventional
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PKCs, bind acidic phospholipids in a Ca2+-dependent manner. Five conserved aspartate
residues in the top loops and at the top of the |3-strands (Figure 4) are responsible for
co-ordinating a cluster of two or three Ca2+ ions at the tip of the domain (Rizo and
Siidhof, 1998). In the absence of Ca2+, the negative charges of these aspartate residues
repel the negatively charged head groups of acidic phospholipids, thereby preventing
membrane binding. However, when Ca2+ binds, it causes a major change in the
electrostatic potential of the domain and allows basic residues in the top loops to make
electrostatic contacts with acidic phospholipids (Shao et al., 1997; Ubach et al., 1998).
The co-ordination spheres of the Ca2+ ions are incomplete when bound to the C2 domain
and are fulfilled by interacting with the phosphate head group of phospholipids. Thus, the
Ca2' ions also act as a bridge between the C2 domain and phospholipids (Verdaguer et
al., 1999). Mutation of the conserved aspartate residues to asparagine prevents the co¬
ordination of Ca2+ ions and abolishes membrane binding (Bolsover et al., 2003).
The second group of C2 domains, which includes those of the novel PKCs, bind
phospholipids in a Ca2+-independent manner. These domains lack some or all of the five
aspartate residues that are found in the top loops of the Ca2+-dependent C2 domains and
consequently do not bind Ca2+. These domains appear to bind to membranes through a
combination of electrostatic and hydrophobic interactions (Ochoa et al., 2001). In the
case of the C2 domain of PKCs, Arg26, Arg32 and Arg50 make electrostatic contacts
with acidic phospholipids, while the hydrophobic side chains of Trp23, Ile89 and Tyr92
insert into the membrane (Ochoa et al., 2001).
Mutations in C2 domains are also found in a number of pathological conditions,
where they cause the miss-location of the affected protein. For example, mutations in
the C2 domain of the lipid phosphatase PTEN, which prevent it from efficiently
binding to the plasma membrane, are found in many sporadic primary cancers,
including endometrial carcinomas and glioblastoma multiform (Eng, 2003).
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PKCa AKRGRIYLKAEV AD EKLHVTVRDAKNL IPMDPNGLS DPYVKLKL IPDPKN
PKC(3l ERRGRIYIQAHI DR DVLIVWRDAKNL VPMDPNGLS DPYVKLKL IPDPKS
PS PI P2
PKCa ESKQXTKT IRS TLNPQWNESF TFKLKPSDKDRR LSVEIWDWD RTTRND
PKCpi ESKQKTKT IRS SLNPEWNETF RFQLKESDKDRR LSVEIWDWD LTSKND
P3 p4 P5
PKCa FMGSLSFGVS ELMKMP ASGWYKLL NQE
PKCPI FMGSLSFCIS ELQKAS VDGWFKLL SQE
p6 P7
Figure 4: Sequence alignment of Ca2+-dependent C2 domains. The C2 domains of PKCa and
PKCpi are shown. Blue boxes indicate the position of P-sheets. The five conserved aspartate




Protein phosphorylation on serine, threonine and tyrosine residues plays a key role in
many signal transduction pathways, regulating the activity of enzymes and transcription
factors, and creating binding sites for protein-interaction domains (including SH2
domains) to nucleate the formation of signalling complexes. As protein kinases regulate
many aspects of cell growth, differentiation and metabolism, their activities are tightly
regulated. Kinase activity in the wrong place or at the wrong time can have disastrous
consequences, leading to cellular transformation and cancer (Kolibaba and Druker, 1997;
Hanahan and Weinberg, 2000). Indeed, the first oncogene to be discovered, v-Src,
encodes an aberrantly regulated tyrosine kinase (Levinson et al., 1978).
The serine/threonine and tyrosine kinases comprise a large family of homologous
proteins that are related by virtue of their conserved catalytic domains (Hanks and
Hunter, 1995), which catalyse the transfer of the y-phosphate of adenosine triphosphate
(ATP) to the hydroxyl group of serine, threonine or tyrosine, generating adenosine
diphosphate (ADP) (Figure 5). Receptor kinases are activated by their cognate ligands
binding to their extracellular domains, while non-receptor kinases are activated by a wide
variety of intracellular signals downstream of cell surface receptors. Efficient substrate
phosphorylation requires the precise co-ordination of ATP in complex with divalent
cations, usually Mg2+ or Mn2+, and substrate. Comparison of the crystal structures of the
catalytic domains of several protein kinases reveals they adopt a similar conformation in
the active state, reflecting the chemical constraints that must be met for phosphotransfer
(Jeffrey et al., 1995, Canagarajah et al, 1997; Hubbard, 1997; Huse and Kuriyan, 2002).
However, they may adopt different conformations in the inactive state, reflecting the
diverse mechanisms that have evolved to regulate the activity of individual kinases (Huse
and Kuriyan, 2002). Structural and biochemical studies indicate that these regulatory
elements determine kinase activity by impinging upon just a few key components of the
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Figure 5: The protein phosphorylation reaction. Protein kinases catalyse the reversible transfer
of the y-phosphate group of ATP to the hydroxyl group of serine, threonine or tyrosine residues.
The reaction is opposed by protein phosphatases, which catalysed the removal of the phosphate
group.
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catalytic domain (Morgan and De Bondt, 1994; Johnson et al., 1996; Hubbard et al.,
1998).
The catalytic domain of the protein kinases is separated into two lobes (Knighton et al.,
1991). The N-terminal lobe is composed of a five-stranded (1-sheet and one prominent
a-helix, designated aC, while the C-terminal lobe is much larger and is predominantly
helical in structure (Figure 6). ATP is bound in a deep cleft between the two lobes where
it sits beneath a highly conserved loop that connects stands pi and (32. This phosphate-
binding loop contains a conserved glycine rich sequence motif, G-X-G-X-c|)-G, where <j) is
usually an aromatic amino acid. The glycine residues approach the a- and P-phosphate
groups of ATP very closely and help co-ordinate them via backbone interactions, while
the conserved aromatic side chain caps the site of phosphate transfer (Hanks and Hunter,
1995; Huse and Kuriyan, 2002). The adenine ring of the nucleotide is enclosed in a
hydrophobic pocket formed by surrounding residues (Hanks and Hunter, 1995).
Peptide substrates bind to the catalytic domain in an extended conformation across the
front of the nucleotide-binding pocket, and are brought into close proximity to the
y-phosphate group of ATP. A centrally located loop, called the activation loop, provides a
platform for the peptide substrate and interacts with residues adjacent to the
phosphoacceptor. In most protein kinases, this loop is phosphorylated when the catalytic
domain is active. Phosphorylation has been shown to stabilise the activation loop in an
open conformation that is permissive to substrate binding (Yamaguchi and Hendrickson,
1996), however, the number and exact placement of phosphorylation sites varies with
individual kinases. In the unphosphorylated state, the activation loop often collapses back
into the active site to block the binding of ATP and substrate, and is therefore an




LRLEVKL GQGCFGE VWMGTW NGT TRVAIKTLK PGTMS PEAFLQEAQVMKKL RHEKLVQ
P1 P2 (33 aC
LYAWS EEPI YIVT EYMSK GS LLDFL KGETGKYLR LPQLVDMAAQIASGMAYVER
P4 P5 cxD aE
Activation loop
MNYVHRDLRAAN ILVG ENLV CKVA DFGLARLIEDNEYTARQGAK FPIKWTA PEAALY
p6 P7 aEF
GRFT IKSDVWSFGILLTELTTKGRVPYPG MVN REVLDQVERG YRMPCPPECP ESLHDLMCQC
aF aG aH
WRKEP EERPT FEYLQAFLE DYFTSTEP
al
Figure 6: Organisation of the catalytic domain of Src. The catalytic domain of Src is shown,
red and blue boxes indicate the positions of a-helices and (3-strands, respectively. The N-terminal
lobe is comprised of strands (31, (32, p3, P4, P5 and helix aC. The C-terminal lobe is comprised of
strands P7, P8 and helices aD, aE, otEF, aF, aG, ocH and od. The ATP binding loop and
activation loop are highlighted. Adapted from Xu et al. (1997).
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Optimal phosphotransfer requires the precise spatial arrangement of several catalytic
residues that are absolutely conserved among protein kinases, namely Lys295, Glu310,
Asp386 and Asp404 (chicken Src numbering). These basic and acidic amino acids form a
network of interactions that are required for the co-ordination of ATP and substrate.
Asp386 interacts with the attacking hydroxyl group of the substrate to position it properly
for phosphorylation, while Asp404 binds the divalent cation (Mg2* in the case of Src) that
is required for nucleotide recognition (Huse and Kuriyan, 2002). Asp404 forms part of a
highly conserved D-F-G motif that is situated at the base of the activation loop. The
structure of this motif and in particular the conformation of Asp404 is tightly coupled to
the phosphorylation status of the activation loop, and in many protein kinases ATP can
only be oriented productively when it is phosphorylated (Huse and Kuriyan, 2002).
Lys295 also makes crucial contacts with the a- and (3-phosphate groups of ATP,
positioning them properly for catalysis. This residue lies in the cleft between the N- and
C-terminal lobes, where it is stabilised and oriented by forming a salt bridge with Glu310
in helix aC (Yamaguchi and Hendrickson, 1996). The integrity of the Lys295-Glu310
interaction is critical for enzyme activity. Structural studies of the active and inactive
forms of Src family kinases have revealed some of the mechanism whereby enzyme
activity may be regulated by altering the spatial orientation of these conserved catalytic
residues (Xu et al., 1997; Yamaguchi and Hendrickson, 1996).
Regulation of the Src family kinases
The Src family non-receptor tyrosine kinases play an important role in signal transduction
by many cell surface receptors, including receptor tyrosine kinases, integrins, and
GPCRs. To date, nine family members have been cloned in mammals (Src, Yes, Yrk,
Fyn, Fgr, Lyn, Hck, Lck and Blk). While Src, Fyn and Yes are ubiquitously expressed,
the other family members are much more restricted in their tissue distribution. Each
shares a common modular structure consisting of a unique N-terminal domain that
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contains a myristoylation sequence, an SH3 domain, an SH2 domain, a catalytic domain,
and a short C-terminal tail that includes an important conserved tyrosine residue (Tyr527
in chicken Src) (Figure 7).
Myristoylation of Src family kinases allows them to associate with cell membranes. All
N-myristoylated proteins begin with the sequence Met-Gly. The initiating methionine is
removed by methionine amino peptidase and myristate, a 14 carbon saturated fatty acid
moiety, is attached to the a-amino group of the N-terminal glycine residue via a stable
amide link in a reaction that is catalysed by N-myristoyl transferase (Gordon et al.,
1991). Studies of myristoylated proteins have established that the addition of myristate
occurs co-translationally and that the N-terminal glycine is absolutely required for this
reaction, however, no strict consensus sequence has been identified (Wilcox et al., 1987).
Covalent modification by fatty acid acylation occurs on a wide variety of signalling
proteins and plays a key role in controlling their subcellular localisation and therefore
interaction with substrates and regulatory molecules. Indeed, non-myristoylated, activated
mutant forms of Src are incapable of transforming cells (Kamps et al., 1985), indicating
that membrane targeting is crucial for enzyme function.
Because the Src family kinases are potent oncogenes, they are under tight control and
have low basal enzyme activity. Structural and biochemical studies have shown that they
are maintained in an assembled inactive conformation by intramolecular interactions
involving their SH2 and SH3 domains (Eck et al., 1994; Williams et al., 1997; Xu et al.,
1997). In quiescent cells, the conserved tyrosine residue in the C-terminal tail is
phosphorylated by C-terminal Src kinase (Csk) (Nada et al., 1991; Okada et al., 1991),
thereby creating a binding site (pY-Q-P-G) for the SH2 domain. When the SH2 domain
binds to the phosphorylated tail, it causes the molecule to adopt a closed conformation in
which the N- and C-terminal lobes of the catalytic domain are not properly aligned for











lu Human Src(536 amino acids)
Figure 7: Structural organisation of chicken and human Src. Src has a modular structure
comprising an SH3 domain, an SH2 domain and a conserved catalytic domain. The N-terminus
contains a myristoylation sequence. The C-termius contains two regulatory tyrosine residues,
Tyr416 and Tyr527 in chicken Src, and Tyr419 and Tyr 530 in human Src. Tyr416/419 lie within
the activation loop of the catalytic domain.
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rich sequence in the linker between the SH2 and catalytic domains (Superti-Furga et al.,
1993). In v-Src, there is a C-terminal truncation that deletes the conserved tyrosine
residue. The loss of this important regulatory element contributes to the transforming
activity of the oncoprotein (Takeya and Hanafusa, 1983). Similarly, mutation of Tyr527
to phenylalanine results in constitutive enzyme activity (Kmiecik and Shalloway, 1987;
Cartwright et al., 1987).
In the assembled inactive conformation, the activation loop adopts an ordered helical
structure that occupies the cleft between the N- and C-terminal lobes of the catalytic
domain (Xu et al., 1999). This prevents substrate binding in two ways; the helix
physically occupies the space where the peptide should sit, and it stabilises the activation
loop in a conformation in which the peptide recognition site is not fully formed (Xu et al.,
1997). The regulatory phosphorylation site in the activation loop, Tyr416, intercalates
into a hydrophobic pocket that is formed by Phe278, Ile411, Phe424 and Pro425 and thus
is unavailable for phosphorylation (Xu et al., 1999). The interactions around Tyr419 also
stabilises the closed conformation of the catalytic domain by helping to fix the relative
orientation of the N- and C-terminal lobes (Xu et al., 1999). Residues at the base of the
activation loop interact closely with the N-terminal lobe, causing helix aC to swing away
from the active site, which prevents Glu310 from interacting with Lys295 (Xu et al.,
1997). In the inactive conformation, Glu310 is stabilised by forming a salt bridge with
Arg409 and by interactions with Tyr382, while Lys295 forms a salt bridge with Asp404
(Xu et al., 1999). This results in a non-productive alignment of the phosphate groups of
ATP.
During Src activation, the C-terminal regulatory tyrosine is dephosphorylated or
displaced from the SH2 domain by a high affinity ligand. Protein tyrosine phosphatase a
(PTPa) and protein tyrosine phosphatase IB (PTP1B) have been proposed to regulate Src
activity by dephosphorylating pTyr527. Evidence for this has been provided from studies
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of fibroblasts from PTPa and PTP1B knockout mice, which have reduced levels of Src
activity in vitro (Ponniah et al., 1999; Dadke and Chemoff, 2003). Binding of the SH2
domain of Src to high affinity phosphopeptide ligands in receptor tyrosine kinases such
as the epidermal growth factor receptor (EGFR), and focal adhesion kinase (FAK) also
leads to Src activation (Oude et al., 1994; Eide et al., 1995). The release of the inhibitory
intramolecular interactions allows Src to adopt an open conformation in which the N- and
C-terminal lobes of the catalytic domain are aligned for catalysis and the activation loop
is disordered. Helix aC rotates inwards, allowing Lys295 to form a salt bridge with
Glu310, thereby freeing Asp404 (Xu et al., 1999). Lys295 and Asp404 can then orient
the phosphate groups of ATP correctly for nucleophilic attack. Once these changes have
taken place, the catalytic domain becomes active and autophosphorylates Tyr416
(Kmiecik et al.„ 1988). The phosphorylated activation loop then packs against the
C-terminal lobe of the kinase domain to form the substrate recognition site and is held in
place by co-ordination of the phosphorylated tyrosine by two conserved arginine
residues, Arg385 and Arg409 (Yamaguchi and Hendrickson, 1996; Xu et al., 1999). The
catalytic domain can then bind and phosphorylate substrate molecules containing the
consensus sequence Y*-I/V-E/D-E/D (Songyang et al., 1995b), where the residue marked
by an asterix represents the phosphoacceptor. Elowever, as the catalytic domain is not
very stringent, the SF12 and SH3 domains also play a key role in substrate selection
(Pellicena and Miller, 2002). Src is inactivated by the dephosphorylation of pTyr416, by
an as yet unidentified protein tyrosine phosphatase, and by phosphorylation of Tyr527 by
Csk.
Many Src substrates are phosphorylated at multiple sites in vitro. In general, multiple
phosphorylations of a protein can proceed by either a processive or a distributive
mechanism (Scott and Miller, 2000). In a distributive mechanism, each phosphorylation
results form a separate collision between enzyme and substrate. In a processive
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mechanism, however, the kinase remains bound to its substrate until it completes all of
the phosphorylations; therefore only one collision between enzyme and substrate is
required. The presence of ligands for Src SH2 and/or SH3 domains in substrate molecules
promotes their stable association with Src and allows processive phosphorylation to occur
(Scott and Miller, 2000; Pellicena and Miller, 2001). Therefore, modular protein-
interaction domains also regulate the kinetics of Src activity.
Regulation of PKCs
Protein phosphorylation and modular interaction domains also play an important role in
regulating the activity of the PKC isozymes, though the mechanism involved is
somewhat different from that described for the Src family kinases. The PKCs comprise a
family of ten related serine/threonine kinases that have been divided into three groups
named conventional, novel and atypical, based on their domain structure and mechanism
of activation (Figure 8) (Newton, 1997). The conventional PKCs (a, pi, pil, y) were the
first to be identified and consist of a conserved catalytic domain, two CI domains
(designated CIA and C1B), a Ca2+-dependent C2 domain, and an auto-inhibitory
pseudosubstrate domain. They are activated by the Ca2+-dependent binding of the C2
domain to phosphatidylserine, and by the CI domains binding diacylglycerol. The novel
PKCs (r|, e, 8, 0) have a similar domain structure, consisting of a conserved catalytic
domain, two CI domains (also designated CIA and C1B), a Ca2+-independent C2
domain, and a pseudosubstrate domain. They are activated by the Ca2_r-independent
binding of the C2 domain to phosphatidylserine, and by the CI domains binding
diacylglycerol. The atypical PKCs (t, Q are smaller molecules, consisting of a conserved
catalytic domain, a single CI domain and a pseudosubstrate domain. They are activated
by the CI domain binding phosphatidylserine, however, they shall not be discussed















Figure 8: Structural organisation of the PKC isozymes. The PKCs have been organised into
three groups named conventional, novel and typical based on their domain structure and
mechanism of activation. The conventional PKC consist of a conserved catalytic domain, two CI
domains (designated a and b), a Ca2 -dependent C2 domain and a pseudosubstrate domain. The
sequence of the pseudosubstrate domain fits the consensus sequence for the catalytic domain but
lacks a phosphorylatable serine or threonine residue. The novel PKCs consist of a conserved
catalytic domain, two CI domains, a Ca2 -independent C2 domain and a pseudosubstrate domain.
The atypical PKCs consist of a conserved catalytic domain, a CI domain and a pseudosubstrate
domain.
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and novel PKCs are not equivalent. In vitro studies have shown that CIA has a much
higher affinity for diacylglycerol than C1B, and they appear to play different roles during
PKC activation as described below (Medkova and Cho, 1999; Wang et al., 2001).
In quiescent cells, conventional and novel PKC isozymes are found in the cytoplasm in
an inactive conformation in which the pseudosubstrate domain is bound in the active site
(Newton, 1997), and CIA is tethered to the C2 domain via a single hydrogen bond
(Bittova et al., 2001). During their activation they translocate to the plasma membrane
where the C2 domain binds phosphatidylserine and C1B binds acidic phospholipids
(Medkova and Cho, 1999). When the C2 domain binds phosphatidylserine, the hydrogen
bond that connects it to CIA is broken and the protein undergoes a conformational
change that induces the insertion of CIA into the lipid bilayer (Bittova et al., 2001).
Membrane penetration allows the side chains of hydrophobic residues in the ligand
binding surface of CIA to interact with diacylglycerol and drives the release of the
pseudosubstrate domain form the active site (Newton, 1997; Medkowa and Cho, 1999;
Bittova et al., 2001). The catalytic domain can then phosphorylate target molecules
containing the consensus sequence R/K-X-S*/T*-X-R/K, where X represents any amino
acid, and the residue marked by an asterix represents the phosphoacceptor (Kennedy and
Krebs, 1991).
The residence time of PKCs at the plasma membrane is relatively short and their
activation is transient unless they are stabilised by other mechanisms. Activated, PKCs
have been shown to bind to a family of intracellular proteins called receptor for activated
C Kinase (RACK), which maintain them in an active conformation and target them to
particular locations within the cell, where they interact with their substrates (Schechtman
and Mochly-Rosen, 2001). Each PKC isozyme has its own specific RACK, which
accounts for the differences observed in the subcellular localisations of the active
enzymes (Kiley et al., 1990; Mochly-Rosen et al., 1990; Disatnik et al., 1994). For
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example, RACK1 binds PKCpiI (Ron et al., 1994) and targets it to integrins (Liliental
and Chang, 1998), while RACK2 binds PKCs and targets it to the golgi (Csukai et al.,
1997). Therefore, the interaction of PKC isozymes with their respective RACKs plays an
important role in regulating access of the active kinase to pools of substrate molecules
and may ultimately determine the outcome of PKC activation (Mochly-Rosen, 1995).
Binding of PKCe to RACK2 has also been reported to increase the efficiency of substrate
phosphorylation (Csukai et al., 1997). Therefore, interactions with RACKs may also
regulate the kinetics of enzyme activity.
Before the conventional and novel PKC isozymes can be activated by extracellular
signalling molecules, they must undergo a process of enzyme maturation. The earliest
translational products are unphosphorylated and are found in association with the
cytoskeleton (Shirai and Saito, 2002). The initial step in the maturation process is the
phosphorylation of Thr500 (PKC-piI numbering) in the activation loop by
phosphoinositde dependent kinase 1 (PDK-1) (Dutil et al., 1998). This aligns the active
site for catalysis, and permits subsequent autophosphorylation of Thr641 and Ser660
(Keranen et al., 1995; Dutil et al., 1998). Once these residues are phosphorylated, the
enzyme assumes its mature conformation and it becomes cytoplasmic (Shirai and Saito,
2002). This series of phosphorylation events is required for the catalytic competence and
correct intracellular localisation of the conventional and novel PKCs in quiescent cells
and therefore represents one of the rate limiting steps for PKC activation. The exception
is PKCS, as phosphorylation of Thr505 in the activation loop is not required for its
catalytic activity. This is because the negative charge of the phosphate group is
compensated for by a glutamic acid residue (Glu500) that is adjacent to the
phosphorylation site (Stempka et al., 1997; Gschwendt, 1999).
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GnRH physiology
GnRH (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly.NH2) plays a pivotal role in the
control of reproduction in mammals. It is synthesised by a small population of neurones
in the median basal hypothalamus whose axons project to the median eminence. GnRH is
secreted in a pulsatile manner into the hypophyseal portal blood vessels, and is carried to
the anterior pituitary where it binds to its cognate receptor on the surface of gonadotroph
cells to stimulate the synthesis and secretion of luteinizing hormone (LH) and follicle
stimulating hormone (FSH), which regulate gonadal function. Each pulse of GnRH
stimulates a pulse of LH secretion, however, FSH pulses are less distinct and it appears to
be constitutively released (Millar, 2002).
The gonadotrophins are structurally related glycoprotein hormones that are composed of
a common a subunit (aGSU) and a hormone-specific (3 subunit (LHP and FSHp) that are
non-covalently associated. In the rat, the gene encoding aGSU is located on chromosome
5, while the genes encoding LHp and FSHp are located on chromosomes 1 and 3,
respectively. In vivo and in vitro studies have shown that the expression of each
gonadotrophin subunit gene is differentially regulated by GnRH (Haisenleder et ah,
1991; Flaisenleder et al., 1993; Haisenleder et al., 1997).
The mammalian GnRH receptor
The mammalian GnRH receptor is a member of the rhodopsin family of G-protein
coupled receptors (GPCRs), which have a common structure consisting of an N-terminal
extracellular domain and seven transmembrane domains, connected by three intracellular
and three extracellular loops. However, the GnRH receptor is unique among the GPCR
superfamily as it does not possess an intracellular C-terminal tail (Tsutsumi et al., 1992,
Eidne et al., 1992). The cytoplasmic tails of GPCRs play a critical role in regulating
signal transduction, and are phosphorylated by a number of serine/threonine kinases,
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including caesin kinase 2 (CK2), protein kinase A (PKA), PKC and the G-protein
coupled receptor kinases (GRKs) (Chaung et al., 1996). Phosphorylation of the tail (and
intracellular loops) causes uncoupling from downstream signalling, and targets the
receptor for internalisation, a process referred to as desensitisation (Chaung et al., 1996).
Because the mammalian GnRH receptor lacks a cytoplasmic tail and is not
phosphorylated, it is not subject to rapid (seconds to minutes) agonist induced
desensitisation (Willars et al., 1999). This feature may be physiologically important as
gonadotroph cells are required to remain responsive to repeated pulses of GnRH, which
would otherwise cause the down regulation of a rapidly desensitising receptor (Willars et
al., 1999).
The rat and mouse GnRH receptors have been shown to be glycosylated at Asn4 and
Asnl8, within the N-terminal domain, while the human receptor is glycoslated at Asnl8
(Millar, 2002). Ligand binding studies have shown that glycosylation plays an important
role in receptor expression and/or stability, and mutation of these conserved asparagine
residues to glutamine decreases cell surface expression (Davidson et al., 1995). The
GnRH receptor is also stabilised by the formation of disulphide bonds between Cysl4 in
the N-terminal domain and Cysl99 in extracellular loop 2, and between Cysl44 in
extracellular loop 1 and Cysl95 in extracellular loop 2 (rat GnRH receptor numbering),
and mutation of these residues to alanine also decreases cell surface expression (Cook
and Eidne, 1997).
Though the three dimensional structure of the mammalian GnRH receptor is not known,
molecular models have been generated based on the structure of bovine rhodopsin, the
only GPCR to be crystallised to date (Palczewski et al., 2000). The seven transmembrane
domains are thought to form a tight bundle enclosing a hydrophilic pocket. GnRH is
thought to bind within this pocket, where it makes contact with residues in the
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extracellular loops and in the superficial regions of the transmembrane domains (Millar et
al., 2004).
GnRH receptor-ligand interactions
Short peptides such as GnRH are highly flexible in solution, and are thought to be able to
adopt many different conformations (Momany, 1976). However, studies by Maliekal et
al. (1997) indicate that GnRH binds to its receptor in a P-II' type conformation, in which
the N- and C-termini of the peptide are closely apposed in space in a horseshoe structure.
This conformation is stabilised by the formation of hydrogen bonds between pGlul and
GlylO.NH2, and between Ser4 and Arg8 (Maliekal et al., 1997). Mutagenesis studies
have identified a number of putative sites of interaction between ligand and receptor.
Arg8 of GnRH is thought to form an electrostatic interaction with Glu301 (in the human,
the equivalent residue is Asp302) at the top of transmembrane domain 7, and mutation of
this residue to glutamine reduces GnRH binding affinity by approximately fifty fold
(Flanagan et al., 1994). The interaction of Arg8 with this conserved acidic residue is
thought to induce or stabilise the P-II' type conformation of the ligand (Fromme et al.,
2001), which facilitates the interaction of pGlul and His2 with Lysl21 in transmembrane
domain 3 (Zhou et al., 1995; Millar, 2002), and GlylO.NH2 with Asnl02 in
transmembrane domain 2 (Davidson et al., 1996).
GnRH receptor signalling
When GnRH binds to its receptor, it is thought to bring about a change in the orientation
of the transmembrane domains. These changes are in turn transmitted to the intracellular
loops and thus uncover previously masked binding sites for G-proteins (Millar et al.,
2004), which are heterotrimeric molecules composed of an a, p and y subunit (Hamm,
1998). The a subunit is responsible for binding and hydrolysing guanine nucleotides,
while the P and y subunits form a dimer that is not dissociable except by denaturation
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(Hamm, 1998). The mammalian GnRH receptor has been shown to couple to Gq and G11
(Hsieh and Martin, 1992). Mutational studies have shown that Ala260 and Arg261, at the
C-terminus of intracellular loop 3, are important sites of interaction with these proteins.
Mutation of Ala260 to leucine, isoleucine, lysine, glutamate or phenylalanine causes
uncoupling of the receptor from downstream signalling (Myburgh et al., 1998). Similarly,
mutation of Arg261 to glutamine also causes uncoupling. This mutation has been found
in some cases of hypogonadotrophic hypogonadism in the human (de Roux et al., 1999).
In the inactive state, the a subunit of the G-protein has guanine diphosphate (GDP)
bound in the active site, and has a high affinity for the Py dimer. When Gq or Gil
interact with an activated GnRH receptor, the a subunits exchanges bound GDP for
guanine trisphosphate (GTP) and undergoes a conformational change that reduces its
affinity for the Py dimer leading to its dissociation from the complex (Hamm, 1998). Both
the a subunit and the Py dimer can then interact with their effectors to initiate
downstream signalling. Signalling is terminated by the intrinsic GTPase activity of the a
subunit, which hydrolyses GTP to GDP. When the a subunit has GDP bound in the
active site, it has a low affinity for its effectors, thereby promoting its re-association with
the Py dimer (Hamm, 1998). The GTPase activity of the a subunit is stimulated by
members of the RGS family of proteins, which bind to it via their conserved RGS domain
and stimulate GTP hydrolysis (Hamm, 1998).
Both Gaq and Gall have been shown to activate PLC-pl, which hydrolyses
PtdIns(4,5)P2 in the plasma membrane to generate the second messengers Ins(l,4,5)P3
and diacylglycerol (Smrcka and Sternweis, 1993). PLC-pi is a modular protein
consisting of an N-terminal PH domain, four EF hand motifs, a catalytic domain, a Ca2+-
independent C2 domain, and a 400 amino acid long C-terminal tail. The PH domain binds
inositol lipids and targets PLC-pi to the plasma membrane (Wang et al., 1999a), while
the C2 domain binds Gaq, leading to the allosteric activation of the catalytic domain
47
(Wang et al., 1999b). Interestingly, the C2 domains of the PLCs do not appear to bind
phospholipids and therefore represent a novel protein-interaction module, with functions
that are distinct from those of other C2 domains (Wang et al., 1999b). The C-terminal tail
of PLC-pi also contacts Gaq and is required for the full activation of the catalytic
domain. In addition, it functions as a GTPase activating protein, which stimulates the
hydrolysis of GTP by Gaq, to terminate G-protein signalling (Paulssen et al., 1996).
The Ins(l,4,5)P3 that is generated by the PLC-(31 mediated hydrolysis of PtdIns(4,5)P2
binds to its intracellular receptor in the membrane of organelles to trigger the release of
Ca2+ from non-mitochondiral stores, which stimulates LH secretion (Stojilkovic et al.,
1994). Studies of cultured rat gonadotroph cells have shown that GnRH preferentially
stimulates the release of Ca2+ from structures called subsurface cisternae, which lie just
beneath the plasma membrane, close to the sites of hormone secretion (Tse et al., 1997).
(ja2+ entry through voltage gated Ca2+ channels does not appear to stimulate hormone
exocytosis in these cells (Tse et al., 1993). Ca2+ has also been shown to stimulate
gonadotrophin subunit gene transcription and therefore also plays a role in regulating
gonadotrophin synthesis (Haisenleder et al., 2001).
Many of the effects ascribed to Ca2+ are mediated by the serine/threonine kinase
Ca27calmodulin dependent kinase II (CaMKII), which is activated by binding
Ca27calmodulin. CamKII exists as a holoenzyme complex composed of eight to twelve
a, p, y and 8 subunits, mixed together at random (Bennet et al., 1983; Kuret and
Schulman, 1984). Each subunit contains a conserved catalytic domain, an autoinhibitory
pseudosubstrate domain, and a C-terminal association domain that is necessary and
sufficient for holoenzyme formation (Shen and Meyer, 1998; Hudmon and Schulman,
2002). They are organised into a ring like structure that allows them to behave
independently of one another for enzyme activity and Ca2+/calmodulin binding (Hudmon
and Schulman, 2002). In quiescent cells, the pseudosubstrate domain is bound in the
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active site, preventing phosphorylation of potential substrates. When a CaMKII subunit
binds Ca2+/calmodulin, it undergoes a conformational change that drives the release of
the pseudosubstrate domain from the active site. Binding of Ca27calmodulin (to the
subunits of CaMKII) is 1:1 in solution (Meyer et al., 1992), and maximal activation of
the holoenzyme appears to require stoichiometric binding (Katoh and Fujisawa, 1991).
The catalytic domain then autophosphorylates a conserved threonine residue (Thr286 in
the a subunit, Thr287 in the (3, y and 5 subunit), within the pseudosubstrate domain. As a
result, the enzyme becomes autonomous in its activity and no longer requires
Ca2+/calmodulin to be bound (Hanson et al., 1989; Waxham et al., 1990). Subsequent
dephosphorylation of this residue converts CaMKII back to its Ca2+/calmodulin
dependent state (Lai et al., 1986; Schworer et al., 1986). In cultured rat gonadotroph
cells, GnRH has been shown to activate CaMKII by inducing the autophosphorylation of
Thr286/287, and CamKII activity is required for the induction of aGSU, LHP and FSHp
gene expression by GnRH (Haisenleder et al., 2003). However, the substrates of CaMKII
in these cells are currently unknown.
The second messenger activities of Ins(l,4,5)P3 and Ca2+ are tightly regulated in cells.
Ins(l,4,5)P3 signalling is terminated by the actions of an inositol-5-phosphatase, which
dephosphorylates the D5 position of the inositol ring to produce I(1,4)P2, and by an
inositol-3-kinase which phosphorylates the D3 position of the inositol ring to produce
Ins(l,3,4,5)P4 (Shears, 1992). Neither of these molecules is able to bind the Ins(l,4,5)P3
receptor or trigger Ca2+ release from internal stores. Ca2+ is pumped back into organelles
or out of the cell by a membrane bound Ca2+ pump, to return the cytoplasmic
concentration of the ion to a low level of around 100 nM in resting cells (Alberts et al.,
1994).
The diacylglycerol that is generated by the PLC-pi mediated hydrolysis of PtdIns(4,5)P2
allosterically activates conventional and novel PKC isozymes as previously described.
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PKC has been shown to play an important role in GnRH receptor signalling (Stojilkovic
et al., 1994). In cultured rat gonadotroph cells, activation of PKC with phorbol esters or
the diacylglycerol analogue sn-l,2-dioctanoylglycerol stimulates aGSU and LHp gene
expression, and LH secretion (Haisenleder et al., 1995). However, like CaMKII, the
substrates ofPKC in these cells are currently unknown.
The activity of conventional and novel PKC isozymes is negatively regulated by the
DGKs, which phosphorylate diacylglycerol to produce phosphatidic acid. To date, nine
isoforms of DGK have been identified in mammals (Topham and Prescott, 1999), which
have been divided into five groups based on their structural organisation (Figure 9). All
of the DGKs contain a bipartite catalytic domain that is responsible for phosphorylating
diacylglycerol, and either two or three CI domains (Topham and Prescott, 1999). The CI
domain closest to the catalytic domain is highly conserved and features a unique 15
amino acid extension that is required for efficient substrate phosphorylation. It has been
proposed that this sequence helps the CI domain to present diacylglyerol to the catalytic
domain, though how this is achieved is currently not understood (van Blitterswijk and
Houssa, 2000).
The catalytic domain of the DGKs shares some sequence similarity with those of the
protein kinases, including a putative ATP binding loop that contains the conserved
sequence motif G-X-G-X-X-G, where X represents any amino acid (Luo et al., 2004).
However, in several DGK isoforms the two lobes of the catalytic domain are separated by
a 300 amino acid long serine/threonine rich insertion, indicating that they may function as
two independent units for catalysis (Luo et al., 2004a). Such long inserts are not seen in
the catalytic domain of any known protein kinase. In addition, the DGKs feature a wide
variety of protein- and lipid-interaction domains, including elongation factor (EF) hand
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Figure 9: Structural organisation of the diacylglycerol kinase isozymes. Mammalian DGKs
are divided into five families (Type I-V) according to their domain structure. All dicaylglycerol
kinases share a common bipartite catalytic domain and two or three CI domains. In addition, the
posses a wide variety ofmodular interaction domains which define their class. Type I DGKs have
two EF hands motifs (EF) that bind calcium. Type II DGK have a PH domain that binds
phosphoinositides and a SAM domain that mediates homo- and hetero-oligomerisation of
proteins. Type III DGKs are the simplest in structure and do not contain any other recognisable
domains. Type IV DGKs have two tandem Ankyrin repeats (ANK) that may mediate protein-
protein interactions. Type V DGKs have three CI domain and an Ras association (RA) domain
that is found in several proteins that interact with the small GTPase Ras.
motifs, ankyrin repeats, and pleckstrin homology (PH) domains (Figure 9). The presence
of such diverse interaction modules suggests very precise regulation of these proteins by
extracellular signalling molecules, however, very little is currently known regarding their
mechanism of activation. Furthermore, the isoforms ofDGK that are activated by GnRH
in pituitary gonadotroph cells are unknown.
Studies of cultured rat gonadotroph cells have also shown that GnRH activates the
extracellular signal regulated kinases (ERK) 1 and 2 (Mitchell et al., 1994; Haisenleder et
al., 1998), which play an important role in regulating gene expression programmes in
mammalian cells by phosphorylating transcription factors and their co-regulatory proteins
in the cytoplasm and nucleus (Yang et al., 2003). Inhibition of this pathway significantly
inhibits aGSU and FSHP gene transcription in these cells in response to GnRH
(Haisenleder et al., 1998), indicating that these kinases play an important role in the
control of gonadotrophin synthesis.
ERK 1 and 2 are activated through a conserved cascade of protein kinases often operating
downstream of the small GTPase Ras, which is targeted to the plasma membrane by fatty
acid acylation and/or prenylation (Resh, 1996). Ras is activated by extracellular
signalling molecules through the membrane recruitment of guanine nucleotide exchange
factors such as Son-of-sevenless (Sos), which stimulate it to exchange bound GDP for
GTP (Aronheim et al., 1994). When Ras binds GTP, it undergoes a conformational
change (Hu and Redfield, 1993) that allows it to interact with the serine/threonine kinase
Raf-1 via its effector domain. Raf-1 is thereby recruited to the plasma membrane where it
is activated. The mechanism of Raf-1 activation by extracellular signalling molecules is
complex and remains poorly understood, however, protein phosphorylation by Src family
kinases has been shown to be important in this process. Src phosphorylates Raf-1 at
Tyr340 and Tyr341 (Marais et al., 1995), which lie just N-terminal to the catalytic
domain. Phosphorylation of these residues is thought to bring about a conformational
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change in the molecule that contributes to its activation (Cutler et al., 1998).
Furthermore, mutation of these amino acids to phenylalanine has been shown to abolish
Raf-1 activity in vitro (Marais et al., 1995). In addition, Raf-1 can be activated
independently of Ras by PKC (Seger and Krebs, 1995; Benard et al., 2001), which has
been shown to phosphorylate Ser499 within the activation loop of the catalytic domain
(Kolch et al., 1993). Mutation of this residue to alanine abolishes Raf-1 activation by
phorbol esters (which activate PKC), but not by Ras and Src (Kolch et al., 1993),
indicating that several different signals may converge at the level of Raf-1 to activate the
ERK signalling cascade in mammalian cells.
Once activated, Raf-1 phosphorylates the dual specificity serine/threonine and tyrosine
kinases MAP and ERK kinase (MEK) 1 and 2 at Ser218 and Ser222 (MEK1 numbering)
within their activation loops, leading to their activation. These kinases in turn activate
ERK 1 and 2 by phosphorylating them at Thrl83 and Tyrl85 (ERK 2 numbering) within
their activation loops. Phosphorylation of these residues correctly aligns the N- and C-
terminal lobes of the catalytic domain for phosphotransfer and leads to the refolding of
the activation loop to form the substrate binding pocket (Canagarajah et al., 1997). ERK
1 and 2 then phosphorylate substrates containing the consensus sequence P-X-S*/T*-P,
where X represents a neutral or basic amino acid, and the residue marked by an asterix
represents the phosphoacceptor (Clark-Lewis et al., 1991; Gonzalez et al., 1991). In
contrast, most other serine/threonine kinases actively exclude substrates with proline
residues in the S*/T* +1 position (Songyang et al., 1994).
Specificity of signalling through the ERK cascade is maintained by the direct interaction
of the successive kinases; Raf-1 binds to MEK 1 and 2, which in turn bind to ERK 1 and
2 (Kolch, 2000). In addition, the scaffolding protein KSR has been shown to bind Raf-1,
MEK and ERK in vitro and in vivo, and can assemble them into an organised signalling
module (Therrien et al., 1996; Michaud et al., 1997; Yu et al., 1998). While a low level
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of KSR expression has been shown to facilitate ERK activation, over expression of this
protein has an inhibitory effect (Cacace et al., 1999). Such a dose-dependent reversal in
effect is typical for a scaffolding protein that can only assemble its clients when present
in an appropriate stoichiometric ratio, but disperses signalling complexes when over-
expressed (Kolch, 2000).
Once activated, ERK 2 has been shown to homodimerise and translocate from the
cytoplasm to the nucleus, where it can phosphorylate nuclear substrates (Khokhlatchev et
al., 1998). When phosphorylated at Thrl83, ERK 2 undergoes a conformational change
that exposes a hydrophobic patch on its surface promoting homodimerisation
(Canagarajah et al., 1997). Because the size of the ERK 2 dimer exceeds the limit for
passive diffusion through the nuclear pore complex (approximately 40 KDa), it must be
actively transported into the nucleus. Nuclear import is controlled by a family of proteins
called importins, which recognise specific nuclear localisation sequences in target
molecules (Hood and Silver, 1999). Because ERK 2 does not contain a recognisable
nuclear localisation sequence, dimerisation may facilitate nuclear shuttling by allowing
the association of the dimer with an additional transport protein. Alternatively, a
functional nuclear localisation sequence may be created from two non-contiguous
stretches of amino acids, however, this remains to be determined (Khokhlatchev et al.,
1998). The requirement for phosphorylation and dimersation of ERK 2 for nuclear
translocation is reminiscent of the mechanism of activation of the signal transducers and
activators of transcription (STAT) proteins by cytokine receptors (Sekimoto et al., 1996),
and is emerging as a common theme in the control of nucleo-cytoplasmic shuttling of
proteins (Hood and Silver, 1999).
Studies in the aT3-l gonadotroph cell line have shown that GnRH activates ERK 1 and 2
via PKC (Sim et al., 1995; Sundaresan et al., 1996; Reiss et al., 1997), which can directly
activate Raf-1 (Benard et al., 2001), and via a protein tyrosine kinase that is required for
54
the Ras dependent activation of Raf-1 (Benard et al., 2001). Protein tyrosine
phosphorylation has been shown to be important for the activation of ERK 1 and 2 by
many GPCRs (Delia Rocca et al., 1999), however, the identity of the tyrosine kinase(s)
involved in the activation of this pathway by GnRH are uncertain. In aT3-l cells GnRH
has been reported to activate Src, and inhibition of Src family kinases with
pharmacological inhibitors, or by over-expression of CSK, significantly inhibits ERK
activation (Grosse et al., 2000; Benard et al., 2001). In addition, Grosse et al. (2000) have
shown that the GnRH receptor can trans-activate the epidermal growth factor receptor
(EGFR) in this cell line, and that EGFR kinase activity is also required for the activation
of ERK 1 and 2 (by GnRH). However, several other studies have failed to show EGFR
dependent activation of the ERK signalling cascade in aT3-l cells, indicating that more
than one protein tyrosine kinase may be involved (Benard et al., 2001; Bonfil et al.,
2004). Benard et al. (2001) have reported that GnRH can activate focal adhesion kinase
(FAK) in these cells, which has been shown to be involved in the activation of ERK 1
and 2 by many other neuropeptide hormones that bind Gq coupled receptors (Zachary et
al., 1992; Sinnett-Smith et al., 1993). Activation ofFAK by GnRH may therefore provide
an alternative means for activating this signalling pathway, independently of the EGFR.
However, as over-expression of FAK-related non-kinase (FRNK), which can function as
a dominant negative inhibitor of FAK dependent signalling, did not significantly inhibit
the activation of ERK 1 and 2 by GnRH in aT3-l cells (Benard et al., 2001), it remains
to be demonstrated conclusively if FAK is indeed involved. The reason for the
differences in results published by these groups is not clear, however, it is possible that
under different growth conditions, populations of cells may be selected that exhibit
different repertoires of signalling molecules, or preferences for particular pathways.
Several other studies have sought to identify the G-proteins involved in the activation of
ERK 1 and 2 by the GnRH receptor. While an early study indicated that ERK activation
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by GnRH was mediated by Gi in aT3-l cells (Sim et al., 1995), subsequent studies have
failed to observe any effect of pertussis toxin, which ADP ribosylates and inactivates Gai
(Reiss et al., 1997; Grosse et al., 2000), and the activation of this pathway is generally
thought to proceed via Gq/11 (Grosse et al., 2000). Furthermore, a recent study in the
LPT2 gonadotroph cell line has shown that ERK activation by GnRH can be blocked by
cell permeable inhibitors of Gaq but not Gai (Liu et al., 2002).
The trans-activation of the EGFR by Gq/11 coupled GPCRs has been shown to be
mediated by a membrane metalloproteinase that cleaves heparin-binding epidermal
growth factor (EGF) from the cell surface. The soluble ligand then acts in an autocrine
manner on the EGFR (Prenzel et al., 1999; Dong et al., 1999). Cleavage of heparin-
binding EGF is thought to be mediated by metalloproteinases and is sensitive to the broad
range metalloproteinase inhibitor batimastat (Schafer et al., 2004). GnRH has been
shown to activate several matrix metalloproteinases (MMP), including MMP-2 and -9
(Roelle et al., 2003).
The EGFR is a receptor tyrosine kinase, which belongs to the ErbB/HER family. When it
binds ligand, it undergoes a conformational change that leads to receptor dimerisation,
activation of the catalytic domain, and trans-autophosphorylation. Though the EGFR has
emerged as an important drug target in cancer therapy, the mechanism of activation of the
catalytic domain remains poorly understood. Unlike other receptor tyrosine kinases, it
does not appear to require the phosphorylation of residues within the activation loop for
its activity. In the unphosphorylated state, the activation loop assumes an open
conformation that is permissive to substrate binding. This is due to the presence of four
glutamic acid residues (Glu841, 842, 844 and 847) within the loop that compensate for
the negative charge of the phosphate group (Stamos et al., 2002). However, the catalytic
domain is somehow maintained in an inactive conformation by the extracellular domain
until it binds ligand. Evidence for this is provided for by the oncoprotein v-Erb, in which
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truncation of the extracellular portion of the receptor results in constitutive kinase
activity, and leads to cellular transformation and cancer (Downward et al., 1984).
Autophosphorylation of the EGFR functions to recruit cytoplasmic proteins to the
receptor that couple it to downstream signalling pathways, including the ERK cascade
(Schlessinger, 2000). Autophosphorylation ofTyrl068 creates a high affinity binding site
(pY-I-N-Q) for the SH2 domain of the adapter protein Growth factor receptor bound 2
(Grb2) (Batzer et al., 1994), which binds Sos with its SH3 domain and thereby recruits it
to the activated receptor (Egan et al., 1994). In addition, autophosphorylation of the
EGFR at Tyrll48 and Tyrll73 creates docking sites for the adapter protein She, which
binds pTyrll73 (pY-L-R-V) via its SH2 domain (Batzer et al., 1994), and pTyrll48 (N-
P-D-pY) via its phosphotyrosine binding (PTB) domain (Sakaguchi et al., 1998). PTB
domains offer an alternative means of recognition of phosphotyrosine motifs in proteins
and recognise the core sequence N-P-X-pY, where X represents any amino acid (Blaikie
et al., 1994; Gustafson et al., 1995). She is then phosphorylated at Tyr317 by Src, which
is also recruited to and activated by the EGFR, to create an additional binding site (pY-L-
R-N) for the SH2 domain of Grb2 (Gotoh et al., 1997). Once recruited to the EGFR, Sos
then activates Ras at the membrane to initiate the activation ofERK 1 and 2.
Several other Gq/11 coupled GPCRs, including those of the neuropeptide hormones
bombesin, bradykinin, endothelin, gastrin and vasopressin have been shown to induce the
tyrosine phosphorylation of the non-receptor tyrosine kinase FAK (Zachary et al., 1992;
Sinnett-Smith et al., 1993). FAK phosphorylation requires the activation of members of
the Rho family of small GTPases (Rankin et al., 1994), which play a key role in
regulating the organisation of the actin cytoskeleton in eukaryotic cells (Hall 1998). The
most extensively characterised members of this family are RhoA, Racl and Cdc42. Like
Ras, these proteins act as molecular switches that cycle between GTP and GDP bound
states. When they bind GTP they undergo a conformational change that allows them to
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interact with effector molecules, which regulate actin dynamics. The intrinsic GTPase
activity of the proteins then returns them to the inactive GDP bound state to terminate
signal transduction (Van Aelst and D'Souza Schorey, 1997). Proper control of the actin
cytoskeleton requires the precise spatial and temporal regulation of these proteins, which
is orchestrated by a wide range of guanine nucleotide exchange factors and GTPase
activating proteins, and by the GDP-dissociation inhibitor Rho-GDI (Bishop and Hall,
2000). In quiescent cells, the Rho family GTPases are found in the cytoplasm in
association with Rho-GDI, which maintains them in the inactive (GDP bound) state
(Ueda et al., 1990). During activation by extracellular signalling molecules, they
dissociate from this complex and translocate to the plasma membrane, where they are
activated by their respective guanine nucleotide exchange factors, and can interact with
effectors (Bokoch et al., 1994).
Activation of RhoA typically leads to the formation of stress fibres (Ridley and Hall,
1992), which are contractile bundles of actin and myosin filaments (actinomyosin) that
resemble tiny myofibrils found in muscle cells (Alberts et al., 1994). The stress fibres are
anchored to the plasma membrane at focal adhesions, where aggregated integrin receptors
bind to the ECM on the outside of the cell and the actin microfilaments on the inside.
Integrins are heterodimeric molecules that are assembled from a pool of 17 a subunits
and 8 P subunits, to give rise to 23 different receptors that can bind a wide variety of
extracellular matrix proteins (Darribere et al., 2000). Most integrins involved in the
formation of focal adhesions belong to the pi and P3 families. For cells grown in serum,
vitronectin is normally the extracellular matrix protein that is adsorbed to the surface of
the dish, and focal adhesions form containing the avP3 integrin. For cells plated on
surfaces coated with fibronectin, focal adhesions normally contain the a5pi integrin
(Burridge and Chrzanowska-Wodnicka, 1996). A large number of cytoplasmic proteins
associate with integrins at focal adhesions. The structural proteins a-actinin, talin and
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vinculin provide a physical link between the integrin and actin microfilaments. FAK is
specifically targeted to focal adhesions by a unique 150 amino acid focal adhesion
targeting domain located at its C-terminus (Hildebrand et al., 1993), which contains
sequences that are responsible for binding talin and another focal adhesion protein,
paxillin (Chen et al., 1995; Hayashi et al., 2002).
The formation of stress fibres and focal adhesions following the activation of RhoA is
mediated by Rho kinase, which inhibits the activity of myosin light chain phosphatase
(Kimura et al., 1996), and directly phosphorylates the light chains of non-muscle myosin-
II (Amano et al., 1996). Light chain phosphorylation induces a conformational change in
myosin that promotes the formation of bipolar filaments containing 15-20 molecules. It
also exposes an actin binding site, which promotes the formation of actinomyosin, and
stimulates myosin ATPase activity. This leads to the contraction of actinomyosin, which
generates tension within the filament (Alberts et al., 1994). Myosin also cross-links
adjacent filaments, and bundles them together to form the prominent stress fibres that are
seen following the activation ofRhoA. It is the bundling of actinomycin into stress fibres
that leads to the aggregation of integrins at the plasma membrane to form focal adhesions
(Burridge and Chrzanowska-Wodnicka, 1996).
In contrast, activation of Racl and Cdc42 by extracellular signalling molecules stimulates
actin polymerisation at the cell cortex, leading to the formation of lamellipodia and
filopodia, respectively (Ridley et al., 1992; Nobes and Hall, 1995). These effects are
regulated by Racl and Cdc42 through their interaction with members of the Wiscott-
Aldrich Syndrome protein (WASp)/Scar family of proteins, which stimulate the Arp2/3
complex to nucleate the formation of new actin filaments (Machesky and Insall, 1998;
Machesky et al., 1999). Though actin is found at high concentrations in cells (up to 100
pM) it does not spontaneously polymerise due to the inherent instability of dimers and
trimers. The Arp2/3 complex stimulates the formation of actin filaments by stabilising
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actin trimers to allow the filament to grow beyond this critical length. Once nucleated,
new filaments grow rapidly towards the plasma membrane until capped by proteins such
as gelsolin and capping protein (Millard et al., 2004). The Arp2/3 complex also binds to
the sides and ends of existing actin filaments to stimulate filament branching, creating the
dense cortical actin network that is seen in lamellipodia and filopodia (Amann and
Pollard, 2001).
The mammalian WASp/Scar family consists of five members; WASp, N-WASp, and
Scar-1, -2 and -3. The C-termini of these proteins contains a conserved module that is
responsible for binding and activating the Arp2/3 complex (Machesky et al., 1999;
Suetsugu et al., 1999). The N-termini of WASp and N-WASp contain a Cdc42/Rac
interactive binding (CRIB) domain that binds Cdc42 (Higgs and Pollard, 2000; Rohatgi
et al., 2000). The N-termini of the Scar proteins contains a unique Scar homology domain
of unknown function (Millard et al., 2004).
In quiescent cells, WASp an N-WASp adopt an assembled inhibitory conformation in
which the CRIB domain is bound to the C-terminus of the protein, preventing interactions
with the Arp2/3 complex (Kim et al., 2000). When Cdc42 is activated, it undergoes a
conformational change that allows it to bind to the CRIB domain, which relieves this
inhibitory interaction, and allows WASp and N-WASp to interact with the Arp2/3
complex (Kim et al., 2000). In addition, Src has been shown to phosphorylate WASp at
Tyr291, adjacent to the CRIB domain (Cory et al., 2002). Phosphorylation of this residue
correlates with increased rates of actin polymerisation in vitro and may help to stabilise
the active conformation of WASp (Cory et al., 2002). When Cdc42 hydrolyses GTP to
GDP, it dissociates from WASp and N-WASP, allowing them to return to their
autoinhibited state.
As the Scar proteins do not contain a CRIB domain, their activity is regulated in a very
different manner by Racl. In quiescent cells, Scarl is found in the cytoplasm in
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association with four other proteins, namely PIR121, Napl25, Abi-2 and HSPC300,
which maintain it in an inactive state (Eden et al., 2002). When Racl is activated by
extracellular signalling molecules, it binds to this complex, causing the dissociation of
Scarl and HSPC300. Scarl can then activate the Arp2/3 complex (Eden et al., 2002).
In addition to stimulating actin polymerisation at the cell cortex, Racl and Cdc42 also
induce the formation of focal complexes, small clusters of integrins and associated
proteins, that provide anchor points for the cell as it extends its plasma membrane to form
lamellipodia and filopodia (Nobes and Hall, 1995). Though smaller than focal adhesions,
these structures contain many of the same components, including vinculin, paxillin and
FAK (Nobes and Hall, 1995; Hotchin and Hall, 1995). Several studies indicate that the
GnRH receptor can activate Rac (Levi et al., 1998; Allen et al., 2002), and that Rac is
involved in the activation ofERK 1 and 2 by GnRH (Allen et al., 2002).
The aggregation of integrins in focal adhesions and focal complexes (collectively referred
to as focal contacts) leads to the tyrosine phosphorylation of FAK, and the activation of
ERK 1 and 2 (Chen et al., 1994; Miyamoto et al., 1995). It is thought that when integrins
become aggregated in these structures, FAK forms dimers and oligomers that trans-
autophosphorylate each other at Tyr397 (Leu and Maa, 2002; Katz et al., 2002), though it
remains unknown how oligomerisation may regulate the activity of the catalytic domain.
Autophosphorylation of Tyr397 creates a high affinity binding site (pY-A-E-I) for the
SH2 domain of Src, which recruits it to the focal contact (Eide et al., 1995). Src also
binds to FAK via its SH3 domain, which recognises the sequence R-A-L-P-S-I-P-K-L
that is approximately twenty amino acids N-terminal to Tyr397 (Thomas et al., 1998).
The sequence of this motif is almost identical to the optimal ligand identified for the SH3
domain of Src by Yu et al. (1994). By binding to FAK at these sites, the inhibitory
intramolecular interactions that maintain Src in the inactive conformation are relieved,
leading to the activation of its catalytic domain. Src then phosphorylates FAK on a
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number of additional tyrosine residues, including Tyr576, Tyr577, and Tyr925 (Schaller
et al., 1999). Tyr576 and Tyr577 lie within the activation loop and phosphorylation of
these residues helps to stabilise the active conformation of the catalytic domain, which
allows FAK to phosphorylate exogenous substrates (Calalb et al., 1995). Phosphorylation
of Tyr925 creates a high affinity binding site (pY-E-N-V) for the SH2 domain of Grb2
(Schlaepfer et al., 1994), which recruits Sos to the plasma membrane, where it activates
Ras as described.
The use of either the EGFR or FAK by Gq/11 coupled receptors was originally though to
represented functional redundancy within the system. However, recent studies suggest
that this may not be the case. Activation of ERK by the EGFR typically results in the
translocation of the active enzymes to the nucleus (Horgan and Stork, 2003; Luttrell and
Luttrell, 2003). In contrast, ERK activated by FAK localises to focal contacts (Fincham et
al., 2000; Luttrell and Luttrell, 2003). Therefore, the mechanism of ERK 1 and 2
activation used by a GPCR may determine the localisation of the active enzymes within
the cell and promote the phosphorylation of a particular subset of substrates.
Aims
Tyrosine kinases such as the EGFR and FAK play an important role in the activation of
ERK 1 and 2 by many Gq/11 coupled GPCRs, creating dockings sites for Grb2, which
recruits Sos to the plasma membrane. Because the molecular events that lead to the
activation of ERK 1 and 2 by the GnRH receptor were not well understood when this
project was started, the initial aim was to investigate the role of protein tyrosine
phosphorylation in this pathway. Subsequently, it was decided to use proteomic
techniques to identify novel substrates of tyrosine kinases that may be involved in other
aspects of GnRH receptor signalling. As Src was found to play a key role in the
activation of ERK 1 and 2, and features SH2 and SH3 domains that mediate specific
molecular interactions, it was selected as the molecule upon which this study would be
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based. A HEK 293 cell line stably expressing the rat GnRH receptor was used as a model
for the majority of the experiments described in this thesis.
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Materials and Methods
This chapter details the methods and laboratory techniques used throughout this thesis.
Unless otherwise indicated all chemicals and reagents were from Sigma Aldrich. For
details of the antibodies and cDNA constructs used during the course of these studies
readers are directed to appendices A and B, at the back of this thesis.
Preparation of competent DH5a cells
A glycerol stock of E. coli strain DH5a was streaked out on a LB-agar plate and grown
overnight at 37°C. A single colony was picked, inoculated into 5 ml of LB medium, and
incubated for 16 hours at 37°C with constant shaking. 1 ml was then used to inoculate
100 ml of LB medium containing 20 mM MgSCL, and the culture grown until an
absorbance (600 nm) of 0.4 - 0.6 was reached. The culture was then chilled on ice and
bacteria harvested by centrifugation at 4,500 xg for 5 minutes at 4°C. All subsequent
steps were performed in a cold room using pre-chilled solutions and plasticware, as
competent cells are highly sensitive to elevated temperatures. The cell pellet was gently
resuspended in 40 ml of 30 mM potassium acetate, 10 mM CaCl2, 50 mM MnCL, 100
mM RbCl, 15% glycerol (pH 5.8) and collected by centrifugation at 4,500 xg for 10
minutes at 4°C. Cells were then suspended in 4 ml of 10 mM PIPES, 75 mM CaCl2, 10
mM RbCl, 15% glycerol (pH 6.5) and divided into 100 pi aliquots. The competent cells
were frozen in a dry ice/ethanol bath and stored at -70°C until use.
Transformation of competent cells
Cells were thawed on ice and incubated with 10 ng ofplasmid DNA for 30 minutes. They
were then warmed to 42°C for 30 seconds and returned to ice for a further 2 minutes. 1 ml
of LB medium was added, and the bacteria incubated for 1 hour at 37°C with constant
shaking. 100 pi of the culture was then streaked out on a LB-agar plate containing
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selective antibiotic and incubated overnight at 37°C. Ampicilin was routinely used at 100
pg/ml and kanamycin at 50 pg/ml.
Preparation of plasmid DNA
A single colony of transformed bacteria was picked and inoculated into 5 ml of LB
medium containing selective antibiotic. The culture was grown overnight at 37°C with
constant shaking. The following evening, 1 ml was used to inoculate 250 ml of fresh LB
medium containing selective antibiotic, and the culture grown for a further 12 hours.
Plasmid DNA was purified using Qiagen maxiprep columns and eluted in TE buffer (10
mM Tris-HCl (pH8), ImM EDTA) according to the manufacturers instructions. DNA
was examined by agarose gel electrophoresis and the concentration determined by
reading the absorbance at 260 nm using a spectrophotometer.
Preparation of glycerol stocks of transformed bacteria
Glycerol stocks of transformed E. coli were made by adding 100 pi of 80% glycerol to
900 pi of bacterial culture that had been grown to stationary phase overnight. Vials were
inverted to mix the glycerol, frozen in a dry ice/ethanol bath, and stored at -70°C. To
recover the bacteria, a sterile inoculating loop was used to scrape the surface of the frozen
culture. Bacteria were streaked out on a LB-agar plate containing selective antibiotic and
grown overnight at 37°C. A single colony was picked and plasmid DNA prepared as
described.
Agarose gel electrophoresis
1 to 2% agarose gels were prepared in TAE buffer (40 mM Tris, 320 mM acetic acid,
ImM EDTA, pH 7.2). Plasmid DNA, PCR products and restriction digests were
separated at 80 V for 2 hours, stained with ethidium bromide and visualised under
ultraviolet light using a transilluminator. For preparative work a 366 nm light source was
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used in order to minimise photo nicking and dimerisation of DNA. DNA was recovered
from agarose gel slices using a QIAquick gel extraction kit (Qiagen) according to the
manufacturers instructions.
Restriction digest of DNA
Single and double digests ofPCR products and vectors were performed in a volume of 20
pi using 1 unit of restriction enzyme in an appropriate buffer, chosen to give maximum
activity of the enzyme(s). All restriction enzymes and buffers were from Promega.
Digestions were performed at 37°C for 3 hours and enzymes heat inactivated at 65°C for
10 minutes where appropriate. DNA was fractionated by agarose gel electrophoresis and
the required bands cut from the gel with a clean scalpel. DNA was recovered by gel
extraction as described.
Ligation of DNA
PCR products were ligated into linearised vector with cohesive ends using T4 DNA
ligase (Promega). A molar ratio of 1:3 to 1:5 vectors:insert was normally used. The mass
of insert required for each ligation was calculated using the formula below:
100 ng of vector x kb size of insert , . . insert2
x molar ratio of = ng of insert
kb size of vector vector
100 ng of vector and the appropriate mass of insert were added to an Eppendorf tube and
made up to a volume of 8 pi with distilled water. Samples were heated to 45°C for 5
minutes then chilled on ice. 1 pi of 10 x T4 DNA ligase buffer (300 mM Tris-HCl (pH
7.8), 100 mM MgCl2, 100 mM DTT, 100 mM ATP) and 1 pi of enzyme were then added,
to give a final volume of 10 pi, and the reaction allowed to proceed for 2 hours at 22°C.
Control reactions were set up with either vector alone or insert alone. 1 pi of the ligation
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mixture was then used to transform competent DH5a E. coli, and transformants selected
on LB-agar plates containing selective antibiotic as described. Single colonies of
transformants were picked and inoculated into 5ml of LB medium containing antibiotic
and grown overnight at 37°C with constant shaking. Bacteria were then harvested by
centrifugation at 5,000 xg for 5 minutes and plasmid DNA prepared using Qiagen
miniprep columns according to the manufacturers instructions. Restriction digests were
performed to confirm the presence ofDNA inserts and plasmids sequenced to ensure that
the inserts did not contain any mutations. Sequencing reactions were carried out by Miss
Nancy Nelson in the genomics and proteomics group at the MRC human reproductive
sciences unit.
Cell culture
HEK 293 cells stably transfected with the rat GnRH receptor (designated SCL60 cells)
were maintained in DMEM supplemented with 10% fetal calf serum, penicillin (50
IU/ml), streptomycin (50 mg/ml), G418 sulphate (0.5 mg/ml) and L-glutamine (4 mM) at
37°C in a humidified atmosphere of 5% carbon dioxide and 95% air. L(3T2 gonadotroph
cells were grown on Matrigel (BD Biosciences) coated plasticware in DMEM
supplemented with 10% fetal calf serum, penicillin (50 IU/ml), streptomycin (50 mg/ml),
and L-glutamine (4 mM) at 37°C in a humidified atmosphere of 5% carbon dioxide and
95% air.
Cell lines were routinely passaged twice weekly by enzymatic dispersal with trypsin-
EDTA. Briefly, the medium was removed from confluent cultures and cells washed three
times with 10 ml of PBS. 2 ml of 0.5 x trypsin-EDTA was then added to each 162 cm2
flask (Coming Costar), and the flasks returned to the incubator for 2 - 5 minutes. After
the cells had been dispersed, 8 ml of growth medium was added to quench the trypsin.
SCL60 cells were routinely split 1:3, while LPT2 cells were split 1:2.
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Dispersed cells were diluted 1:10 in DMEM and counted using a Nebauer
haemocytometer. Cells were counted in all four counting areas of the haemocytometer
and an average taken to give the cell number x 105 per ml. They were then seeded into
100 mm dishes or 12 well plates (Coming Costar) for experiments, as required.
Cryopreservation and resucitation of cell lines
Stocks of each cell line were stored at -196°C under liquid nitrogen in cryoprotectant
(10% DMSO (v/v) in fetal calf semm). Cells were recovered from the liquid nitrogen
store and rapidly warmed to 37°C in a water bath. They were then gently resuspended in
10 ml of growth medium and seeded into flasks. Frozen stocks were preserved by
banking cells for the first few passages after they were resuscitated. Confluent cultures
were passaged as described, and cells collected by centrifugation at 500 xg for 5 minutes.
The medium was decanted and the cell pellet gently resuspended in cryoprotectant,
aliquoted into vials, and frozen at -70°C in a cryo 1°C freezing container (Nalgene). Vials
were then transferred to liquid nitrogen for long term storage.
Transient transfection by Ca2+-phosphate precipitation
SCL60 cells were transfected by the calcium phosphate precipitation method (Wigler et
al., 1979). Briefly, 3xl06 cells were seeded into 100 mm dishes and allowed to attach
overnight. 3 hours prior to beginning the transfection, the medium was removed and
replaced with fresh growth medium. 10 pg of plasmid DNA was diluted to 438 pi in
sterile deionised water and 62 pi of 2 M CaCl2 added, to give a volume of 500 pi. The
DNA/CaCl2 solution was added drop wise to 500 pi of 2 x HEPES-buffered saline (50
mM HEPES, 280 mM NaCl, 1.5 mM Na2HP04, pH 7.1) whilst gently vortexing, and the
mixture incubated at room temperature for 2 minutes to allow the calcium phosphate and
DNA to from a co-precipitate. The transfection solution was then added drop wise to the
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cells, and cultures incubated overnight. After 16 hours the medium was removed and
replaced with fresh growth medium. Cells were harvested for experiments 48 hours later.
Transient transfection with Superfect reagent
LDT2 cells were transfected with Superfect transfection reagent (Qiagen) using 5 pi
of Superfect per pg of plasmid DNA. 3 x 106 cells were seeded into 100 mm dishes
and allowed to attach overnight. The following day 10 pg of plasmid DNA was
diluted to a volume of 300 pi with Optimem serum free medium (Gibco) in a sterile
Eppendorf tube. 50 pi of Superfect was added, and the mixture incubated at room
temperature for 10 minutes to allow the DNA to complex with the Superfect reagent.
The transfection solution was then added to the cells in 3 ml of growth medium for 5
hours. Cells were harvested for experiments 48 hours later.
Preparation of pharmacological inhibitors and ligands
Stock solutions of AG1478, BAPTA-AM, cytochalasin-D, GF109203X, herbimycin
A, latrunculin-B, PD 98059, PP2, Ro-318220, wortmannin, and U73122 (all from
Calbiochem) were prepared in dimethyl sulphoxide and stored at -20°C. RGDS and
RGES were dissolved in sterile water and stored at -20°C. C. difficile Toxin B
(Calbiochem), EGF and GnRH were dissolved in sterile water and stored at 4°C.
Inositol phosphate formation assay
SCL60 cells were seeded into 12 well plates at a density of 3 x 105 cells per well and
allowed to attach overnight. The following day, the medium was removed and
monolayers washed with 1 ml of PBS. Cells were then incubated for 48 hours in 1 ml of
inositol-free DMEM (Gibco) containing 1% dialysed fetal calf serum, penicillin (50
IU/ml), streptomycin (50 mg/ml), L-glutamine (4 mM) and 1 pCi/ml myo-[3H]inositol
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(Amersham Pharmacia Biotech). After 48 hours, the medium was removed and
monolayers washed with 1 ml of pre-warmed assay buffer (140 mM NaCl, 20 mM
HEPES (pH 7.2), 8 mM glucose, 4 mM KC1, 1 mM MgCl2, 1 mM CaCl2, 1 mg/ml fatty
acid free bovine serum albumin) to remove extracellular myo-[3H]inositol. Cells were
then incubated at 37°C in 500 pi of assay buffer containing 10 mM LiCl for 30 to 60
minutes to block inositol phosphatases, then stimulated with GnRH as described in the
figure legends. Pretreatment with chemical inhibitors was performed during the pre¬
incubation with LiCl.
Following stimulation with GnRH, the assay buffer was removed and cells lysed in 500
pi of 10 mM formic acid for 30 minutes at 4°C. 3H-inositol phosphates were purified by
ion-exchange chromatography using AG1-X8 resin (Formate form, Bio-Rad
Laboratories). The formic acid extract was added to 500 pi of a 50% slurry of AG1-X8
resin prepared in distilled water and mixed by vortexing. The supernatant was removed
and the resin washed with 1ml of distilled water followed by 1 ml of 60 mM ammonium
formate, 5 mM sodium tetraborate. Bound inositol phosphates were then eluted with 1 ml
of 1 M ammonium formate, 0.1 M formic acid. 800 pi of eluate was mixed with 2.5 ml of
Optiphase 3 scintillant (Perkin Elmer), and the radioactivity measured by liquid
scintillation spectroscopy. Assays were performed in triplicate.
Immunocytochemistry and confocal microscopy
SCL60 Cells were seeded into poly-L-lysine coated 8-well chamber slides (Labtech) at a
density of 7.5 x 104 cells per well and allowed to attach overnight. The medium was
removed, cells washed with PBS, and incubated overnight in serum free DMEM
containing penicillin (50 IU/ml), streptomycin (50 mg/ml), and 10 mM HEPES (pH 7.4).
Quiescent cells were then stimulated with GnRH the following morning. Chemical
inhibitors were added in serum free DMEM as described in the figure legends.
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After stimulation with GnRH, cells were washed with chilled PBS and fixed with ice cold
methanol at -20°C for 10 minutes. The fixed cells were then blocked with 10% fetal calf
serum, 1% bovine serum albumin in PBS (blocking solution) for 1 hour at room
temperature. Anti- tyrosine tubulin and p-actin antibodies were added at a 1:100 dilution
in blocking solution overnight at 4°C. Cells were then washed three times with PBS and
FITC conjugated secondary antibody added at a 1:200 dilution in blocking solution for 1
hour at room temperature. After three washes with PBS, slides were mounted in
permafluor mounting medium (Immunotech) and left to dry overnight in the dark.
Filamentous actin was stained with fluorescently labeled phalloidin. After fixing in ice
cold methanol, cells were incubated for 1 hour at room temperature with a 1:50 dilution
of Alexfluor-568 phalloidin (Molecular Probes) prepared in PBS. The cells were then
washed three times with PBS and mounted as above. For phase contrast microscopy, cells
were fixed in ice cold methanol and mounted as described.
Confocal microscopy was performed on a Zeiss LSM 510 laser scanning microscope
with a 40 x 1.4 numerical aperture oil immersion lens. Images were exported to
Adobe photoshop.
Fractionating cells with non-ionic detergents
The distinct chemical properties of non-ionic detergents allow cells to be fractionated into
specific subcellular proteomes for immune precipitation and Western blotting studies.
Cytoplasmic and nuclear extracts were prepared by gently lysing cells in a NP-40
(Calbiochem) based buffer. Low concentrations of this detergent do not solubilise the
nuclear lamina, allowing the nuclei to be separated from the cytosol and other organelles
by low speed centrifugation. In contrast, lysis in Triton X-100 based buffer allows the
isolation of detergent insoluble cytoskeletons from the majority of other cellular material.
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The cytoskeleton and associated proteins can then be extracted under depolymerising
conditions and separated from insoluble material by centrifugation.
Preparation of cytoplasmic and nuclear extracts
SCL60 cells were seeded into 100mm dishes at a density of 3 x 106 cells per dish and
allowed to attach overnight. The medium was removed, cells washed with PBS, and
incubated overnight in serum free DMEM containing penicillin (50 IU/ml), streptomycin
(50 mg/ml), and 10 mM HEPES (pH 7.4). Quiescent cells were stimulated with GnRH or
EGF the following morning. Chemical inhibitors were added in serum free DMEM as
described in the figure legends.
Following stimulation with ligands, cells were washed with chilled PBS and lysed on ice
for 10 minutes in 800 pi ofNP-40 based lysis buffer (0.5% NP40, 150 mM NaCl, 5 mM
HEPES (pH 7.4), 2 mM EDTA (pH 8.0), 100 pM Na3V04, 1 mM PMSF and 10 pg/ml
leupeptin). Lysates were recovered to Eppendorf tubes and nuclei sedimented by
centrifugation at 1,000 xg for 3 minutes at 4°C. Cytoplasmic lysates were recovered to
fresh tubes and clarified by centrifugation at 15,000 xg for 15 minutes at 4°C. The nuclear
pellet was washed twice in 800 pi ofNP-40 buffer to remove contaminating cytoplasmic
proteins and solubilised in 50 pi of NP-40 buffer containing 0.2% (w/v) SDS. Insoluble
material was sedimented by centrifugation at 15,000 xg for 15 minutes at 4°C and nuclear
lysates recovered to fresh tubes.
Protein tyrosine phosphorylation was analysed by immune precipitating proteins from
cytoplasmic extracts with anti-phosphotyrosine (PY20) agarose conjugated antibody,
followed by Western blotting. Phosphorylation of transiently expressed epitope tagged
proteins was analysed by immune precipitating proteins from cytoplasmic extracts with
anti-myc or anti-HA agarose conjugated antibodies as appropriate, followed by Western
blotting. ERK activation was analysed by Western blotting cytoplasmic and nuclear
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extracts with a phosphospecific antibody that recognises the active phosphorylated forms
of ERK 1 and 2. Protein interactions were analysed by reciprocal immune precipitation
and Western blotting or by two-dimensional gel electrophoresis and MALDI-ToF mass
spectrometry.
Preparation of cytoskeletal extracts
Cytoskeletal extracts were prepared essentially according to Payrastre et al. (1991).
SCL60 cells were seeded into 100mm dishes at a density of 3 x 106 cells per dish and
allowed to attach overnight. The medium was removed, cells washed with PBS, and
incubated overnight in semm free DMEM containing penicillin (50 IU/ml), streptomycin
(50 mg/ml), and 10 mM HEPES (pH 7.4). Quiescent cells were stimulated with GnRH
the following morning.
Following stimulation with GnRH, cells were washed with chilled PBS and lysed on ice
for 15 minutes in 1 ml of Triton X-100 based lysis buffer (0.5% Triton X-100, 20 mM
HEPES (pH 7.4), 50 mM NaCl, 1 mM EGTA, 100 pM Na3V04, 1 mM PMSF and 10
pg/ml leupeptin). Lysates were recovered to Eppendorf tubes and insoluble material
collected by centrifugation at 12,000 xg for 1 minute at 4°C. The pellet was washed four
times in 1 ml of 20 mM HEPES (pH 7.4), 50 mM NaCl, 1 mM EGTA, 100 pM Na3V04,
1 mM PMSF and 10 pg/ml leupeptin, to remove contaminating cytoplasmic proteins, and
cytoskeletons extracted in 2 ml of 0.6 M KI, 100 mM PIPES (pH 6.5), 100 mM KCL,
100 pM Na3V04, 1 mM PMSF and 10 pg/ml leupeptin for 20 - 30 minutes at 4°C with
gentle shaking. Insoluble material was sedimented by centrifugation at 15,000 xg for 15
minutes at 4°C and the supernatant recovered to a fresh tube. The association of proteins
with Triton X-100 insoluble cytoskeletons was then confirmed by immune precipitation
and Western blotting.
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Determination of protein concentration
Protein concentrations were determined according to Bradford (1976), using BSA as
standard. A standard curve (0-2 mg/ml) was prepared by serial dilution of a 10 mg/ml
stock of BSA in the appropriate buffer. 10 pi of each sample or standard was added to 1
ml of Bradford assay reagent (Bio-Rad Laboratories) in an Eppendorf tube, vortexed to
mix, and incubated at room temperature for 5 minutes. The absorbance was then
measured at 595 nm using a spectrophotometer. A standard curve was plotted and the
concentration ofprotein in each sample calculated from the equation of the line.
Immune precipitation
Proteins were immune precipitated from 500 pg of cell extract with 20 pi of agarose
conjugated antibody, or 2 pg of antiserum plus 20 pi of a 30% slurry of protein A plus
protein G agarose resin (Calbiochem). Briefly, samples were tumbled overnight with
antibody and protein A plus protein G agarose resin (if required) at 4°C and immune
precipitates collected by centrifugation at 5,000 xg for 10 minutes at 4°C. Immune
complexes were then washed twice in 1ml of NP-40 based lysis buffer to remove
contaminating proteins. To prevent the non-specific binding of proteins to the agarose
matrix, cell extracts were routinely pre-cleared with 20 pi of protein A plus protein G
agarose resin for 1 hour prior to immune precipitating.
SDS-PAGE
Discontinuous Tris-glycine gels were prepared according to Westermeier (1997). 8% and
10% resolving gels were prepared in 1.5 M Tris (pH 8.8), 1% (w/v) SDS, 25% (v/v)
glycerol. 5% stacking gels were prepared in 1.25 M Tris (pH 6.8), 1% (w/v) SDS.
Solutions were degassed for 5 minutes and polymerisation initiated by the addition of
TEMED and APS. The resolving gel was poured and then immediately overlaid with the
stacking gel. The inclusion of 25% glycerol in the resolving gel buffer allows both to be
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cast at the same time without them mixing together. Gels were allowed to polymerise for
1 hour at room temperature and stored at 4°C overnight before use.
Protein extracts were mixed with an equal volume of 2 x SDS-PAGE sample buffer (25
mM Tris-HCl (pH 6.8), 8% SDS, 0.9 M P-mercaptoethanol, 10% (v/v) glycerol), boiled
for 5 minutes and cooled to room temperature. Immune precipitates were routinely
solubilised in 25 pi of SDS-PAGE sample buffer, boiled for 5 minutes, cooled to room
temperature, and agarose beads pelleted by centrifugation at maximum speed in a bench
top centrifuge for 1 minute. A Hamilton syringe with a 22 gauge needle was used to load
the gels to prevent agarose resin being accidentally loaded into the wells. Proteins were
resolved by SDS-PAGE using a Mini Protean II electrophoresis system (Bio-Rad
Laboratories). Electrophoresis was routinely performed at 200 V for 1 hour in SDS-
PAGE running buffer (25 mM Tris, 192 mM glycine, 1% (w/v) SDS).
Western blotting
Proteins were transferred from SDS-PAGE gels to PVDF membrane (Perkin Elmer) for
Western blotting using a Novablot semi-dry transfer apparatus (Amersham Pharmacia
Biotech). PVDF membranes were prepared by washing with 100 % methanol for 1
minute, followed several washes with distilled water, and then equilibrated in semi-dry
transfer buffer (20mM Tris, 192 mM glycine, 20% methanol, 0.1% SDS) for 10 minutes.
Three thicknesses of electrode paper were soaked in semi-dry transfer buffer and placed
onto the anode plate of the transfer apparatus. The PVDF membrane was then placed on
top followed by the gel and then another three thicknesses of electrode paper wetted with
buffer. Air bubbles were rolled out with a glass test tube, and the cathode plate carefully
placed on top. Proteins were transferred at 12 V for 1 hour.
Following semi-dry transfer, membranes were rinsed in TBS-T (100 mM Tris-HCl (pH
7), 150 mM NaCl, 0.05% Tween 20, 0.05% NP-40) and blocked for 1 hour in 10 ml of
blocking buffer (4% (w/v) bovine serum albumin in TBS-T) with gentle shaking on a
plate rocker. The blocking buffer was discarded and primary antibody (diluted 1:1,000 in
10 ml of blocking buffer) added for 1 hour. Membranes were washed three times for 10
minutes each in TBS-T, then alkaline-phosphatase conjugated secondary antibody
(diluted 1:10,000 in 10 ml of blocking buffer) added for 1 hour. After three further 10
minute washes in TBS-T, blots were drained and developed with ECF substrate
(Amersham Pharmacia Biotech) for 1 - 5 minutes according to the manufacturers
instructions, and visualised using a Typhoon 9200 scanner (Amersham Pharmacia
Biotech). Bands were quantified using ImageQuant software (Molecular dynamics).
After being scanned, blots were washed in 40% methanol for 30 minutes to remove
precipitated fluorophore and rinsed in TBS-T. Antibodies were then stripped from the
membrane by incubating in 10 ml of 25 mM Tris-HCl (pH 7), 8% (w/v) SDS, 0.72 M
P-mercaptoethanol for 30 minutes at 80°C, followed by three 10 minute washes in
TBS-T.
In vitro protein kinase assay
The kinase activity of FAK and Src was assayed in vitro using rabbit muscle enolase
as substrate. Cytoplasmic extracts were prepared from SCL60 cells as described, and
FAK or Src immune precipitated with 2 Dg of specific antiserum and 20 pi of protein
A plus protein G resin for 4 hours at 4°C. Immune complexes were collected by
centrifugation at 15,000 xg for 10 minutes, washed twice with 1 ml of NP-40 based
lysis buffer, and once with 1ml of 150 mM NaCl, 20 mM HEPES (pH 7.4), 30 mM
MgCb. They were then resuspended in 10 pi of protein kinase assay buffer (150 mM
NaCl, 20 mM HEPES (pH 7.4), 30 mM MgCl2, 100 pM sodium orthovanadate, 10
pCi [D-32P]ATP (3000 Ci/mol; Amersham Pharmacia Biotech), 10 pM cold ATP,
and 0.3 mg/ml rabbit muscle enolase) on ice. The reaction was started by warming
samples to 30°C in a water bath, and samples incubated for 10 minutes. The reaction
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was stopped by returning the samples to ice. 10 pi of SDS-PAGE sample buffer was
then added to each tube, and samples boiled for 5 minutes. Proteins were resolved by
SDS-PAGE as described, and the gels dried onto filter paper for 1 hour at 58°C using
a vacuum gel drier (Bio-Rad Laboratories), wrapped in cellophane and exposed to X-
ray film (Kodak).
Two-dimensional gel electrophoresis of Src immune complexes
Cytoplasmic extracts were prepared from SCL60 cells and Src immune precipitated with
20 pi of anti-Src agarose conjugated antibody as described. Immune precipitates were
then washed three times with 1 ml of Tris-sorbitol buffer (40 mM Tris, 10 mM sorbitol)
to remove contaminating salts, and solubilised in 50 pi of two-dimensional gel
electrophoresis sample buffer (8 M urea, 4% (w/v) CHAPS, 40 mM Tris) for 1 hour at
room temperature.
Proteins were separated according to their isoelectric points using an IPGphor isoelectric
focusing system and immobiline drystrip gels (Amersham Pharmacia Biotech). Samples
were applied to 11cm, pH 3-10 (linear) immobiline strips, in 200 pi of rehydration
solution (8M urea, 2% (w/v) CHAPS and 20 mM DTT), overlayed with mineral oil to
minimise evaporation and urea crystallisation, and strips rehydrated for 12 hours at 30 V.
Isoelectric focusing was then performed as follows; 500 V for lhour, 1,000 V for 1 hour
and 8,000 V for 2 hours (giving a total of 17,500 V hours). Immobiline strips were then
washed in SDS-PAGE equilibration buffer (50 mM Tris-HCl (pH 8.8), 6 M urea, 30%
(v/v) glycerol, 2% (w/v) SDS) containing 1% (w/v) DTT for 10 minutes, followed by a
second 10 minute wash in equilibration buffer containing 4% (w/v) iodoacetamide.
The immobiline strips were then placed onto Excel gel 12-14% SDS-PAGE gels
(Amersham Pharmacia Biotech) and proteins resolved by electrophoresis at 1,000 V
at 20 mA for 45 minutes, followed by 1,000 V at 40 mA for 2 hours 45 min using a
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Multiphor II flat bed system (Amersham Pharmacia Biotech). Proteins were
visualised by staining with silver or coomassie blue.
Silver staining SDS-PAGE gels
Gels were stained using a Hoefer automated gel stainer with a stainless steel tray
(Amersham Pharmacia Biotech). All solutions were prepared with double-distilled water
immediately before use. Following electrophoresis, gels were fixed in 10% glacial acetic
acid in 40% methanol for 30 minutes, washed three times for 5 minutes with distilled
water, and sensitised in 0.02% (w/v) sodium thiosulphate, 200 mM sodium acetate in
30% ethanol for 30 minutes. After three 5 minute washes in distilled water, silver stain
(0.25% (w/v) silver nitrate, 0.015% (w/v) formaldehyde) was added for 20 minutes. Gels
were then washed twice for 1 minute in distilled water and developed with 60 mM
sodium carbonate, 0.0074 % (w/v) formaldehyde for 2 to 5 minutes as required. The
reaction was stopped by the removal of the developer and the addition of 10 mM EDTA
to chelate free silver ions. After 10 minutes the EDTA solution was removed and gels
washed three times for 5 minutes in distilled water. Gels were preserved in 87% (v/v)
glycerol, wrapped in cellophane and stored at 4°C.
Coomassie blue staining SDS-PAGE gels
All solutions were prepared with double distilled water. Following electrophoresis, gels
were fixed and stained in 0.25 % (w/v) Coomassie brilliant blue R250 in
methanol/water/glacial acetic acid (45:45:10) for 1 hour. The stain was removed and gels
destained in several changes ofmethanol/water/glacial acetic acid (45:45:10) for 4 hours.
Gels were then preserved in 87% (v/v) glycerol, wrapped in cellophane and stored at 4°C.
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In-gel tryptic digests and MALDI-ToF mass spectrometry
Protein spots of interest were excised from SDS-PAGE gels with a clean scalpel blade
and recovered to Eppendorf tubes. An equal sized piece was cut from a blank area of the
gel to serve as a control for keratin contamination. The gel slices were dehydrated in 200
pi of 50% acetonitrile and dried under vacuum until all traces of solvent were removed.
Samples were then reduced in 15 pi of 10 mM DTT, 0.2% EDTA, 100 mM ammonium
bicarbonate for 30 minutes at 56°C, cooled to room temperature and alkylated in 50 pi of
50 mM iodoacetamide, 100 mM ammonium bicarbonate for 30 minutes at room
temperature in the dark. After alkylation, gel slices were washed in 200 pi of 100 mM
ammonium bicarbonate for 10 minutes and dehydrated in 200 pi of acetonitrile. Samples
were washed and dehydrated a further two times, then dried under vacuum to constant
weight. The gel pieces were rehydrated in 5 pi of digestion buffer (50 mM ammonium
bicarbonate buffer containing 12.5 ng/ml sequencing grade trypsin) at 37°C for 15
minutes, covered with 10 pi of 50 mM ammonium bicarbonate to prevent them from
drying out, and incubated at 37°C overnight. Peptides were extracted in 50 pi of 5%
formic acid in 50% acetonitrile for 1 hour at room temperature with constant shaking.
The supernatant was recovered to a fresh Eppendorf tube, dried under vacuum, and
peptides resuspended in distilled water. All steps were performed in a laminar flow hood
to minimise keratin contamination. Peptides were desalted using Zip Tips (Millipore) and
analysed by MALDI-ToF mass spectrometry by Dr P. Barran and Dr J. Creanor at the
Department of Chemistry (University of Edinburgh), using a Voyager MALDI-ToF mass
spectrometer (ABI). Proteins were identified from m/z peak lists using MS-Fit
(http://prospector.ucsf.edu) to interrogate the SwissProt protein database
(http://www.expasy.org). The parameters used during database searches are summarised
in Table 1 below. The primary amino acid sequences of proteins identified by mass
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spectrometry were analysed using scansite (http://scansite.mit.edu) to identify potential
protein-interaction domains and phosphorylation sites.
Parameter Setting used
Digest













Table 1: Summary of parameters used in MS-Fit (http://prospector.ucsf.edu) while
searching the SwissProt database (http://www.expasy.org).
Preparation of the pET42a-DGK^
DGKTJ was cloned into pET42a (Novagen) for expression in E. coli as a fusion protein
with an N-terminal GST and 6-His tag. The coding sequence of rat DGK^ was amplified
by PCR from pEGFPBos-DGK^ using primers which contained an EcoRI or Sail
restriction enzyme cut site, for directional cloning into pET42a. Primer sequences were
GCGGCGGAATTCATGGAGCCGCGGGACCC (forward) and CGCCGCGTCGACCT
ACACAGCTGTCTCCTGGTCCT (reverse).
PCR reactions were performed in a Hybaid thermal cycler in a volume of 30 pi
containing; 1 X Thermopol buffer (New England Bioloabs, 10 mM KC1, 10 mM
(NH4)2S04, 20 mM Tris-HCl, 4 mM MgS04, 0.1% Triton X-100, pH8.8), 0.67 mM
dNTPs, 100 ng of each primer, and 1 unit ofDeep VentR DNA polymerase (New England
Biolabs). PCR conditions were as follows; denaturation at 94°C for 5 minutes, followed
by 30 cycles of 94°C for 1 minute, 58°C for 1 minute, and 72°C for 3 minutes, with a
final extension step at 72°C for 10 minutes. PCR product and pET42a vector were
80
digested with EcoRI and Sail, ligated together, and transformed into DH5a competent E.
coli as described.
Single colonies of transformants were picked and inoculated into 5 ml of LB medium
containing antibiotic and grown overnight at 37°C with constant shaking. Plasmid DNA
was purified using Qiagen miniprep columns, and sequenced to ensure that the inserts did
not contain any deleterious mutations. Once the sequence had been verified as correct,
pET42a-DGK£, was transformed into BL21 competent cells (Novagen) for protein
expression.
Expression and purification of recombinant DGK£
A single colony of transformed BL21 cells was inoculated into 5ml of 2YT medium
containing 30 pg/ml kanamycin and incubated at 37°C with constant shaking until an
absorbance (600 nm) of 0.6 was reached. Cultures were stored at 4°C overnight. The
following day 1 ml was inoculated into 100 ml of 2YT medium, and the incubation
continued until an absorbance (600 nm) of 0.6 was reached once again. Protein
expression was then induced with 1 mM IPTG for 4 hours at 37°C with constant shaking.
In initial experiments, recombinant DGK^ was found to be produced as an insoluble
protein and therefore had to be purified under denaturing conditions using Ni2+-NTA
resin (Qiagen). p-mercaptoethanol was included in the column wash buffer to remove
contaminants that had formed disulphide bonds with the fusion protein.
Following the induction of protein expression, bacteria were harvested by centrifugation
at 5,000 xg for 10 minutes and lysed in 10 ml of denaturing lysis buffer (8 M urea, 20
mM sodium phosphate (pH 7.8), 0.5 M NaCl, 1 mM PMSF) for 10 minutes at room
temperature. Lysates were sonicated on ice, insoluble material sedimented by
centrifugation at 15,000 xg for 15 minutes at 4°C, and the clarified lysate recovered to a
fresh tube. Imidazole was added to a final concentration of 10 mM, and the cell free
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extract tumbled with 2 ml of pre-equilibrated Ni2+-NTA resin for 1 hour at 4°C. The resin
was then transferred to a disposable plastic column (Bio-Rad Laboratories) and washed
with 30 ml of denaturing lysis buffer containing 10 mM imidazole, followed by 30 ml of
denaturing wash buffer (8 M urea, 20 mM sodium phosphate (pH 6.5), 0.5 M NaCl, 10
mM imidazole, 10 mM (3-mercaptoethanol). The fusion protein was then refolded on the
column by washing with 30 ml of native wash buffer (20 mM sodium phosphate (pH
7.8), 0.5 M NaCl, 20 mM imidazole) to remove the urea, and eluted with 10 ml of 250
mM imidazole in 20 mM sodium phosphate (pH 7.8), 0.5 M NaCl. 1ml fractions were
collected and the elution of bound proteins monitored by Bradford assay. Fractions
containing recombinant DGKL, were identified by SDS-PAGE and staining with
Coomassie blue and pooled together.
Recombinant DGK<^ was further purified by gel filtration on a 20 ml Sephadex G-150
column, using 20 mM sodium phosphate (pH 7.8), 150 mM NaCl, 10 mM imidazole
as running buffer. 1 ml fractions were collected, and the elution of proteins monitored
by Bradford assay. Fractions that contained recombinant DGKZJ were identified by
SDS-PAGE and staining with Coomassie blue. They were then pooled together and
concentrated in dialysis tubing sprinkled with a little sephadex G-25 to absorb some
of the liquid. The fusion protein was then stored at 4°C until use.
Preparation of Sephadex G-150 gel filtration columns
lg of Sephadex G-150 (bead size 40 - 120 pm) was swollen in 50 ml of 20 mM sodium
phosphate (pH 7.8), 150 mM NaCl, for 5 hours at 80°C in a water bath, then allowed to
cool to room temperature. The resin was carefully poured into a 1 x 25 cm glass column
and allowed to settle under gravity. The column was then equilibrated with running
buffer and the void volume calculated by running dextran blue (average molecular weight
2 x 106 Da) through it.
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Preparation of rat brain Iysates
Brains were obtained from rats, frozen in dry ice/ethanol bath, and stored at -70°C until
required. Tissue was collected from animals that were being euthanised for other
researchers and would otherwise have gone to waste. Brains were homogenised on ice in
1 ml of 0.5% NP40, 20 mM sodium phosphate (pH 7.8), 150 mM NaCl, 100 pM
Na3V04, 1 mM PMSF and 10 pg/ml leupeptin with a glass tissue grinder and lysates
clarified by centrifugation at 15,000 xg for 10 minutes at 4°C. Lysates were recovered to
fresh tubes and the protein concentration determined by Bradford assay. Imidazole was
added to a final concentration of 10 mM before affinity chromatography was performed.
DGK^ affinity chromatography
250 pg of recombinant DGK^ was bound to 50 pi of Ni2+-NTA resin for 1 hour at
4°C and then washed three times with 1ml of wash buffer (0.5% NP-40, 20 mM
sodium phosphate (pH 7.8), 150 mM NaCl, 10 mM imidazole). Immobilised DGK£,
was then incubated for 4 hours at 4°C with 500 pg of rat brain lysate. Beads were
collected by centrifugation at 800 xg for 1 minute and washed twice with 1 ml of
wash buffer. Proteins were solubilised in 50 pi of SDS-PAGE sample buffer, boiled
for 5 minutes and cooled to room temperature. Protein interactions were analysed by
SDS-PAGE and Western blotting. To prevent non-specific binding of proteins to the
Ni2+-NTA resin during affinity chromatography, rat brain lysates were routinely pre-
cleared with 50 pi of resin for 1 hour prior to use.
Diacylglycerol kinase assay
The enzymatic activity of immune precipitated DGK^ was assayed in vitro using 1,2-
dioleoyl-sn-glycerol as substrate, as described by Payrastre et al. (1991). 1,2-dioleoyl-s-n-
glycerol and phosphatidylserine were suspended in chloroform/methanol (1:1) and stored
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at -20°C under nitrogen to prevent their oxidation. The required amount of each lipid was
pipetted into a glass tube and dried under vacuum. Mixed micelles were formed by
adding 100 mM Tris-HCl (pH7.4), 20 mM MgCl2 and sonicating.
Cytoplasmic and Triton X-100 insoluble cytoskeletal extracts were prepared as
described, and DGK<^ immune precipitated with 2 pg of specific antiserum and 20 pi
of protein A plus protein G resin for 4 hours at 4°C. Immune complexes were
collected by centrifugation at 15,000 xg for 10 minutes, then washed twice with 1 ml
of 50 mM Tris-HCl (pH7.4), 10 mM MgCl2. They were then resuspended in lOOpl of
lipid kinase buffer (50 mM Tris-HCl (pH7.4), 10 mM MgCl2, 10 pCi of [y-32P]ATP
(3000 Ci/mol; Amersham Pharmacia Biotech) 60 pM cold ATP, 50 pM 1,2-dioleoyl-
■sw-glycerol, and 100 pM phosphatidylserine) on ice. The reaction was started by
warming samples to 30°C in a water bath, and samples incubated for 10 minutes.
Reactions were terminated by the addition of 400 pi of chloroform/methanol (1:1).
Samples were then vortexed for 10 seconds, and centrifuged at 2,000 xg for 10
minutes to separate the organic and aqueous phases. The aqueous phase was
discarded and the organic phase containing the lipids recovered to a glass test tube.
Solvent was evaporated at 42°C under a stream of cold air, and lipids resuspended in
20 pi of chloroform for analysis by thin layer chromatography.
Thin-layer chromatography
Radio-labeled lipids were spotted onto 20 cm x 20 cm silica gel coated thin-layer
chromatography plates and separated using chloroform/methanol/water/ammonium
hydroxide (60:48:11:1.8) as solvent. Following chromatography, plates were dried for 1
hour in a fume hood to remove all traces of solvent, wrapped in cellophane and exposed
to X-ray film (Kodak). The identity of radiolabeled phosphatidic acid was confirmed by
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running phosphatidic acid standard, staining plates in an iodine chamber, and comparing
Rf values.
Translocation of GFP-tagged DGK^
Membrane translocation of GFP-tagged DGKtJ was observed in L□ T2 cells using a
Zeiss LSM 510 laser scanning microscope with a 40 x 1.4 numerical aperture oil
immersion lens. LPT2 cells were transfected with GFP-DGK^ as described. 24 hours
after transfection, cells were dispersed with 0.5 x trypsin-EDTA and seeded into
matrigel coated 35 mm microscope dishes (MaTek) at a density of 0.25 x 106 cell per
dish. The following evening the medium was removed, cells washed with PBS, and
incubated overnight in serum free DMEM containing penicillin (50 IU/ml),
streptomycin (50 mg/ml), and 10 mM HEPES (pH 7.4). For microscopy, cells were
maintained in serum free DMEM at 37°C in a heated chamber on the microscope
stage, stimulated with GnRFI, and images recorded periodically. Images were
exported to Adobe photoshop. All experiments were repeated at least three times.
Statistical analyses
Data are presented as mean values + or ± the standard error of the mean (SEM). Data
were analysed by Student's T-test or by one way analysis of variance (ANOVA) using
Tukey's pairwise comparison to identify groups, which were significantly different.
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Role of tyrosine kinases in ERK activation by the
GnRH receptor
Introduction
Many GPCRs initiate the activation ofERK 1 and 2 by recruiting the guanine nucleotide
exchange factor Sos to the plasma membrane in association with Grb2, which binds to
tyrosine phosphorylated proteins via its SH2 domain and to Sos via its SH3 domain
(Egan et al., 1994). The EGFR and FAK have both been proposed to act as plasma
membrane scaffolds upon which this Ras activation complex may assemble, and many
Gq coupled GPCRs have been shown to induce their tyrosine phosphorylation (Daub et
al., 1996; Delia Rocca etal., 1999).
The utilisation of different scaffolds for the activation of ERK 1 and 2 was originally
thought to represent functional redundancy within the system. However, experimental
data is now beginning to suggest that this is not the case. Activation of these enzymes by
the EGFR typically results in their translocation of the nucleus (Horgan and Stork, 2003;
Luttrell and Luttrell, 2003). In contrast, activation ofERK 1 and 2 by FAK may spatially
constrain the proteins at the plasma membrane and thus favour the phosphorylation of
proteins in the cytoplasm (Fincham et al., 2000; Luttrell and Luttrell, 2003). Therefore,
the mechanism of ERK activation employed by a GPCR may play an important role in
determining the function of the active enzymes within the cell. In this chapter, the role of
tyrosine kinases in the activation ofERK 1 and 2 by the GnRH receptor is investigated in
SCL60 cells.
Results
Immune precipitation and Western blotting studies revealed that GnRH (100 nM, 10
minutes) induced the tyrosine phosphorylation of four proteins in SCL60 cells, with
molecular weights of 70, 100, 115 and 125 KDa, respectively (Figure 10 A). The major
band was subsequently identified as FAK (Figure 10 B). However, the EGFR was not
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found to be tyrosine phosphorylated following stimulation with GnRH (data not shown).
These results are consistent with previous reports by Reiss et al. (1997) and Johnson et
al. (2000) who showed that GnRH induces the tyrosine phosphorylation of a 125 KDa
protein in aT3-l cells, and suggest that FAK may function as a scaffold for the activation
ofERK 1 and 2 in these cells.
Time course experiments revealed that GnRH induced a rapid and sustained increase in
FAK tyrosine phosphorylation, which reached a maximum at 5 minutes and remained
elevated above basal levels up to 1 hour after stimulation with GnRH (Figure 11 A). The
increase in FAK phosphorylation was found to be significantly different from basal levels
at each time point (P<0.01). The increase in tyrosine phosphorylation was also
accompanied by an increase in the kinase activity of immune precipitated FAK towards
exogenous substrate in vitro (Figure 11 B).
GnRH was also found to activate Src in SCL60 cells. Western blotting anti-
phosphotyrosine immune precipitates with phospho-specific antibodies revealed that
GnRH induced a rapid but transient dephosphorylation of Src at Tyr530, and a sustained
increase in the autophosphorylation of Tyr419 (Figures 12 A and B). Significant
decreases in Tyr530 phosphorylation were observed at the 1 and 2 minute time points
compared to the unstimulated control (P<0.01), while Tyr419 phosphorylation was found
to be significantly increased at each time point examined (compared to the control)
(P<0.01). These events are consistent with the activation of the catalytic domain of Src,
and were accompanied by an increase in the kinase activity of immune precipitated Src
towards exogenous substrate in vitro (Figure 12 C). In all subsequent studies, auto¬
phosphorylation of Src at Tyr419 was used as an indicator of enzyme activation.
The activation of ERK 1 and 2 by GnRH was analysed by Western blotting cytoplasmic
extracts with a phospho-specific antibody that recognises both isoforms when dually
phosphorylated at Thrl83 and Tyrl85 (ERK2 numbering) by MEK 1 or 2. The time
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course ofERK activation was similar to that observed for FAK, reaching a maximum at 5
minutes but remaining elevated above basal 1 hour after treatment (Figure 13 A). The
increase in ERK phosphorylation was found to be significantly different from the
unstimulated control at each time point examined (P<0.01). Western blotting nuclear
extracts revealed that GnRH also induced the nuclear translocation of ERK in SCL60
cells, however, it was found to be much less potent than EGF in this respect (Figure 13
B).
By immune precipitating FAK and Western blotting with antibodies raised against ERK2
and Src, it was found that FAK functions to assemble these proteins together into a
complex. In quiescent SCL60 cells, ERK2 was found to co-precipitate with FAK. The
association between the two proteins did not appear to be altered by GnRH treatment
(Figure 14). FAK was also found to associate with Src. However, this association was
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Figure 10: Identification of proteins that are tyrosine phosphorylated in response to GnRH
in SCL60 cells. Quiescent cells were treated with vehicle or 100 nM GnRH for 10 minutes and
cytoplasmic extracts prepared. Phospho-tyrosine proteins were immune precipitated and analysed
by Western blotting with anti-phospho-tyrosine (A) or anti-FAK (B) antibodies. The band of
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Figure 11: GnRH induces the activation and tyrosine phosphorylation of FAK in SCL60
cells. Quiescent cells were treated with vehicle or 100 nM GnRH and cytoplasmic extracts
prepared. (A) Phospho-tyrosine proteins were immune precipitated and FAK tyrosine
phosphorylation analysed by Western blotting. GnRH induced a significant increase in FAK
tyrosine phosphorylation at each time point versus control (*, P<0.01, by ANOVA and Tukey's
pairwise comparison). Data represent the mean of three separate experiments + SEM. (B) FAK
was immune precipitated and kinase activity assayed in vitro using rabbit muscle enolase as
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Figure 12: GnRH induces the activation of Src in SCL60 cells. Quiescent cells were treated
with vehicle or 100 nM GnRH and cytoplasmic extracts prepared. Phospho-tyrosine proteins were
immune precipitated and Src tyrosine phosphorylation analysed by Western blotting, using
antibodies that recognise Src when phosphorylated at Tyr419 (A) and Tyr530 (B). GnRH induced
a significant increase in Tyr419 phosphorylation at each time point and a significant decrease in
Tyr530 phosphorylation at 1 and 2 minutes versus control (*, P<0.01, by ANOVA and Tukey's
pairwise comparison). Data represent the mean of three separate experiments + SEM. Src was
immune precipitated and kinase activity assayed in vitro using rabbit muscle enolase as substrate




















Figure 13: GnRH induces the activation of ERK1/2 in SCL60 cells. (A) Quiescent cells were
treated with vehicle or 100 nM GnRH and cytoplasmic extracts prepared. GnRH induced a
significant increase in the phosphorylation of ERK 1/2 at each time point versus control (*,
P<0.01, by ANOVA and Tukey's pairwise comparison). Data represent the mean of three separate
experiments + SEM. (B) Quiescent cells were treated with 100 nM GnRH or 10 ng/ml EGF and
nuclear extracts prepared. ERK 1/2 activation was analysed by Western blotting. The immunoblot


























Figure 14: FAK functions as a molecular scaffold for ERK2 and Src in SCL60 cells.
Quiescent cells were treated with vehicle or 100 nM GnRH for 10 minutes and cytoplasmic
extracts prepared. FAK was immune precipitated and Src and ERK2 association analysed by
Western blotting. FAK was immune precipitated with a rabbit polyclonal antibody and Western
blotted with a monoclonal antibody. Src and ERK2 antibodies were rabbit polyclonal antibodies.
The band of approximately 30 KDa in the Src and ERK2 blots is antibody light chain. The
immunoblots shown are representative of three separate experiments.
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Transient transfection studies were performed with FAK point mutants to investigate the
role of the interaction between FAK and Src in the activation of ERK2 by the GnRH
receptor. In these experiments, SCL60 cells were transfected with wild type FAK, or
FAK point mutants that were kinase dead (K454R), unable to bind Src via its SH2
domain (Y397F), or unable to bind Grb2 via its SH2 domain (Y925F), along with myc-
tagged ERK2. Following stimulation with GnRH, the myc-tagged ERK was immune
precipitated from cytoplasmic extracts, and its activation analysed by Western blotting.
Expression of each FAK point mutant significantly inhibited the GnRH induced
phosphorylation ofERK2, compared to the wild type protein (PO.Ol) (Figure 15). These
results indicate that FAK autophosphorylation at Tyr397, association with Src, and
subsequent phosphorylation at Tyr925 by Src are important events in the activation of
ERK2.
A range of pharmacological inhibitors was used to investigate the proximal signals that
lead to the co-ordinated activation of FAK, Src and ERK by GnRH in SCL60 cells. FAK
tyrosine phosphorylation was found to be unaffected by the inhibition of PLC (U73122),
PKC (GF109203X, Ro-318220), PI-3 kinase (wortmannin), MEK (PD98059), EGFR
tyrosine kinase activity (AG1478), or chelation of intracellular calcium (BAPTA-AM).
However, it was sensitive to the inhibition of Src family kinases with PP2 (P<0.01)
(Figure 16). Src Tyr419 autophosphorylation displayed a similar spectrum of
sensitivities, and was only significantly inhibited by pre-treatment with PP2 (P<0.01)
(Figure 17). ERK 1 and 2 phosphorylation was also found to be unaffected by inhibition
of PLC, PI-3 kinase, EGF receptor tyrosine kinase activity, or chelation of intracellular
calcium. However, it was sensitive to inhibition of PKC (GF109203X, PO.05; Ro-
318220, P<0.05), MEK (PO.Ol) and Src family kinases (PO.Ol) (Figure 18).
As FAK and Src are known to be regulated by cell adhesion to the extracellular matrix,
the role of integrins and the actin cytoskeleton in GnRH receptor signalling was
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investigated. Overnight treatment of adherent cells with the fibronectin and vitronectin
fragment R-G-D-S causes the displacement of integrins from the extracellular matrix,
resulting in the dissolution of focal contacts, and the disassembly of the actin
cytoskeleton. Treatment of SCL60 cells with the R-G-D-S peptide completely blocked
FAK tyrosine phosphorylation, while the inactive control peptide R-G-E-S (that does not
bind integrins) had no effect (Figure 19). Disruption of the actin cytoskeleton with
cytochalasin-D or latrunculin-B, also abolished FAK tyrosine phosphorylation (Figure
19). Likewise, Src Tyr419 autophosphorylation was blocked by overnight treatment of
cells with the R-G-D-S peptide, and by treatment with cytochalasin-D and latrunculin-B
(Figure 20), while ERK 1 and 2 phosphorylation was significantly inhibited by treatment
with R-G-D-S (P<0.01), cytochalasin-D (P<0.01) and latrunculin-B (P<0.01) (Figure
4.21).
The Rho family GTPases play an important role in regulating the actin cytoskeleton in
eukaryotic cells. C. difficile Toxin B is a cell permeable bacterial toxin that
monoglucosylates and inactivates RhoA, Racl and Cdc42. Overnight treatment with
Toxin B was found to cause SCL60 cells to develop a rounded phenotype (data not
shown) and significantly inhibited FAK tyrosine phosphorylation (P<0.01), Src Tyr419
autophosphorylation (P<0.01) and ERK 1 and 2 phosphorylation (P<0.01), following
stimulation with GnRH (Figure 22).
Dominant negative cDNA constructs of RhoA (N19RhoA) and Racl (N17Racl) were
then used to investigate whether either of these two proteins were involved in stimulating
FAK tyrosine phosphorylation by GnRH. In these experiments, SCL60 cells were
transfected with HA-tagged FAK, or with HA-tagged FAK plus either N19RhoA or
N17Racl. Following agonist stimulation, HA-tagged FAK was immune precipitated from
cytoplasmic extracts and its phosphorylation status analysed by Western blotting.
Expression of N19RhoA did not significantly inhibit FAK phosphorylation following
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stimulation with GnRH. However, it was abolished by the expression of N17Racl
(Figure 23).
The GnRH receptor also activated PLC in SCL60 cells, leading to the hydrolysis of
PtdIns(4,5)P2. The accumulation of inositol phosphates in the presence of lithium
chloride, which inhibits inositol monophosphatases, was found to be linear up to 1 hour
following stimulation with GnRH (Figure 24 A). While the activation of the ERK
signalling cascade was critically dependent on cell adhesion to the extracellular matrix
and the integrity of the actin cytoskeleton, the activation of PLC was unaffected by
disruption of the actin cytoskeleton with cytochalasin-D or latrunculin-B (Figure 24 B),
indicating that there is a divergence between these two important pathways. The
accumulation of inositol phosphates following stimulation with GnRH was however






























Figure IS: The association of FAK and Src is important for the activation of ERK2 in
SCL60 cells. SCL60 cells were transfected with myc-tagged ERK2 and either wild type FAK,
Y397F FAK, K454R FAK or Y925F FAK. 48 hours after transfection, quiescent cells were
treated with vehicle or 100 nM GnRH for 10 minutes and cytoplasmic extracts prepared. Myc-
tagged ERK2 was immune precipitated and its phosphorylation analysed byWestern blotting. The
expression of Y397F, K454R and Y925F FAK all significantly inhibited the GnRH induced
phosphorylation of Myc-ERK compared to WT FAK (*, PO.01 by ANOVA and Tukey's
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Figure 16: Chemical sensitivities of FAK phosphorylation in SCL60 cells. Quiescent cells
were pre-treated with AG 1478 (100 nM, 30 minutes), BAPTA-AM (50 pM, 30 minutes), GF
109203X (1 pM, 30 minutes), PD 98059 (10 pM, 60 minutes), PP2 (5 pM, 30 min), Ro-318220
(100 nM, 30 min), U73122 (20 pM, 60 minutes) or wortmannin (100 nM, 30 minutes). Controls
received DMSO alone. Cells were then treated with vehicle or 100 nM GnRH for 10 minutes and
cytoplasmic extracts prepared. Phospho-tyrosine proteins were immune precipitated and FAK
phosphorylation analysed by Western blotting. Pretreatment of cells with PP2 significantly
inhibited the GnRH induced tyrosine phosphorylation of FAK (*, PO.01, by ANOVA and
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Figure 17: Chemical sensitivities of Src activation in SCL60 cells. Quiescent cells were pre¬
heated with AG 1478 (100 nM, 30 minutes), BAPTA-AM (50 pM, 30 minutes), GF 109203X (1
pM, 30 minutes), PD 98059 (10 pM, 60 minutes), PP2 (5 pM, 30 min), Ro-318220 (100 nM, 30
min), U73122 (20 pM, 60 minutes) or wortmannin (100 nM, 30 minutes). Controls received
DMSO alone. Cells were then treated with vehicle or 100 nM GnRH for 10 minutes and
cytoplasmic extracts prepared. Phospho-tyrosine proteins were immune precipitated and Src
Tyr419 phosphorylation analysed by Western blotting. Pretreatment of cells with PP2
significantly inhibited the GnRH induced autophosphorylation of Src at Tyr419 (*, P<0.01, by











































































Figure 18: Chemical sensitivities of ERK1/2 activation in SCL60 cells. Quiescent cells were
pre-treated with AG 1478 (100 nM, 30 minutes), BAPTA-AM (50 pM, 30 minutes), GF 109203X
(1 pM, 30 minutes), PD 98059 (10 pM, 60 minutes), PP2 (5 pM, 30 min), Ro-318220 (100 nM,
30 min), U73122 (20 pM, 60 minutes) or wortmannin (100 nM, 30 minutes). Controls received
DMSO alone. Cells were then treated with vehicle or 100 nM GnRH for 10 minutes and
cytoplasmic extracts prepared. ERK1/2 phosphorylation was analysed by Western blotting.
Pretreatment of cells with PD 98059, PP2, GF 109203X and R0-318220 all significantly inhibited
the GnRH induced phosphorylation of ERK1/2 (*, P<0.01; **, P<0.05, by ANOVA and Tukey's











































Figure 19: Role of focal contacts and the actin cytoskeleton in FAK phosphorylation in
SCL60 cells. Quiescent cells were pre-treated with RGDS (1 mM, 16 hours), RGES (1 mM 16
hours), cytochalasin-D (1 pM, 60 minutes) or latrunculin-B (1 pM, 60 minutes). Cells were then
treated with vehicle or 100 nM GnRH for 10 minutes and cytoplasmic extracts prepared.
Phospho-tyrosine proteins were immune precipitated and FAK phosphorylation analysed by
Western blotting. Pretreatment of cells with RGDS, cytochalasin B and latrunculin-D all
significantly inhibited GnRH induced tyrosine phosphorylation of FAK (*, P<0.01, by ANOVA






































Figure 20: Role of focal contacts and the actin cytoskeleton in Src activation in SCL60 cells.
Quiescent cells pre-treated with RGDS (1 mM, 16 hours), RGES (1 mM 16 horns),
cytochalasin-D (1 uM, 60 minutes) or latrunculin-B (1 pM, 60 minutes). Cells were then treated
with vehicle or 100 nM GnRH for 10 minutes and cytoplasmic extracts prepared. Phospho-
tyrosine proteins were immune precipitated and Src Tyr419 phosphorylation analysed by Western
blotting. Pretreatment of cells with RGDS, cytochalasin B and latrunculin-D all significantly
inhibited GnRH induced Src Tyr419 autophosphorylation (*, P<0.01, by ANOVA and Tukey's





























































Figure 21: Role of focal contacts and the actin cytoskeleton in ERK1/2 activation in SCL60
cells. Quiescent cells were pre-treated with RGDS (1 mM, 16 hours), RGES (1 mM 16 hours),
cytochalasin-D (1 pM, 60 minutes) or latrunculin-B (1 pM, 60 minutes). Cells were then treated
with vehicle or 100 nM GnRH for 10 minutes, and cytoplasmic extracts prepared. ERK1/2
phosphorylation was analysed by Western blotting. Pretreatment of cells with RGDS,
cytochalasin B and latrunculin-D all significantly inhibited GnRH induced ERK1/2
phosphorylation (*, P<0.01, by ANOVA and Tukey's pairwise comparison). Data represent the
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Figure 22: Role of Rho family GTPases in the activation of FAK, Src and ERK1/2 in SCL60
cells. Quiescent cells were pre-treated with Toxin B (5 ng/ml, 16 hours). They were then treated
with vehicle or 100 nm GnRH for 10 minutes and cytoplasmic extracts prepared. Phospho-
tyrosine proteins were immune precipitated and FAK phosphorylation (A) and Src Tyr419
phosphorylation (B) analysed by Western blotting. ERK phosphorylation was analysed by
Western blotting cytoplasmic extracts (C). Pretreatment of cells with Toxin B significantly
inhibited GnRH induced FAK, Src Tyr419 and ERK1/2 phosphorylation (*, P<0.01 by ANOVA
and Tukey's pairwise comparison). Toxin B was also found to significantly reduce basal levels of

































Figure 23: GnRH-induced FAK phosphorylation requires Racl in SCL60 cells. Cells were
transfected with HA-tagged FAK and either empty vector, N19RhoA or N17Racl. 48 hours after
transfection, quiescent cells were treated with vehicle or 100 nM GnRH for 10 minutes and
cytoplasmic extracts prepared. HA-tagged FAK was immune precipitated and tyrosine
phosphorylation analysed by Western blotting. Expression of N17 Rac 1 was found to
significantly inhibit the GnRH induced tyrosine phosphorylation of co-expressed HA-FAK (*,









































Figure 24: The activation of PLC by GnRH is not dependent upon the actin cytoskeleton in
SCL60 cells. Cells were labeled with myo-[3H]inositol for 48 hours. (A) Cells were then treated
with vehicle or 100 nm GnRH for 10 to 60 minutes. Inositol phosphates were extracted and the
radioactivity counted. Data represent the mean of three separate experiments ± SEM. (B) Cells
were pretreated with U73122 (20 pM, 60 minutes), cytochalasin-D (1 pM, 60 minutes) or
latrunculin-B (1 pM, 60 minutes). Controls received DMSO alone. They were then treated with
vehicle or 100 nm GnRH for 60 minutes. Inositol phosphates were extracted and the radioactivity
counted. Pretreatment of cells with U73122 significantly inhibited GnRH induced inositol
phosphate accumulation (*, P<0.01 by ANOVA and Tukey's pairwise comparison). Data
represent the mean of three separate experiments + SEM.
106
To provide further evidence for the activation of Racl, the effects of GnRH on cell
morphology and the organisation of the cytoskeleton were examined. Following
stimulation with GnRH, a progressive remodelling of the plasma membrane was
observed under the microscope, cells spreading and forming lamellipodia. Almost every
cell had formed prominent lamellipodia within 30 to 60 minutes of GnRH treatment
(Figure 25). A range of pharmacological inhibitors was used to identify the signalling
pathway(s) that may be involved in this process. Pre-treatment of cells with inhibitors of
PLC. (U73122), PKC (GF109203X, R0-318220), PI-3 kinase (wotmannin) EGFR
tyrosine kinase activity (AG1478) or MEK (PD 98059) had no effect on membrane
remodelling, however, inhibition of Src family kinases with PP2 abolished the formation
of lamellipodia (Figures 26 and 27). The observed changes in cell morphology were
accompanied by the reorganisation of the cytoskeleton. Immunocytochemical studies
revealed that GnRH treatment caused the redistribution of microtubules within the cell,
and stimulated actin polymerisation at the cell cortex (Figure 28). The formation of
filamentous actin networks at the cell cortex was found to be restricted to sites of active
plasma membrane remodelling i.e. within lamellipodia (Figure 29). In accordance with
the observed effects of PP2 on GnRH induced changes in cell morphology, actin
polymerisation was also found to be sensitive to the pharmacological inhibition of Src
family kinases (Figure 29). Western blotting revealed that Src associates with the Triton-
XI00 insoluble cytoskeleton in SCL60 cells. Furthermore, GnRH stimulation lead to a
significant increase in the autophosphorylation of Src (P,0.01) associated with the
cytoskeleton, where it is positioned to participate in the regulation of cortical actin
polymerisation (Figure 30).
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Figure 25: GnRH induces cell spreading and the formation of lammelipodia in SCL60 cells.
Quiescent cells were treated with vehicle (1) or with 100 nM GnRH for 10 minutes (2), 30
minutes (3) or 60 minutes (4). They were then fixed in methanol, and phase contrast images taken
using a Zeiss LSM 510 scanning laser microscope. Images shown are representative of at least
three separate experiments.
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Figure 26: Chemical sensitivities of GnRH induced cell spreading in SCL60 cells. Quiescent
cells were pretreated with 20 pM U73122 for 60 minutes (1 and 2), 100 nM Ro-318220 for 30
minutes (3 and 4), or 1 pM GF109203X for 30 minutes (5 and 6). Cells were then treated with
vehicle (1,3 and 5) or 100 nM GnRH (2,4 and 6) for 30 minutes, fixed in methanol and phase
contrast images taken using a Zeiss LSM 510 scanning laser microscope. Images shown are
representative of at least three separate experiments.
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Figure 27: Chemical sensitivities of GnRH induced cell spreading in SCL60 cells. Quiescent
cells were pretreated with 100 nM wortmannin for 30 minutes (1 and 2), 5 |iM PP2 for 30 minutes
(3 and 4), or 10 pM PD 98059 for 60 minutes (5 and 6). Cells were then treated with vehicle (1,3
and 5) or 100 nM GnRH (2,4 and 6) for 30 minutes, fixed in methanol and phase contrast images






Figure 28: GnRH induced alterations in the organisation of the cytoskeleton in SCL60 cells.
Quiescent cells were treated with vehicle (1,3 and 5) or 100 nM GnRH for 30 minutes (2, 4 and
6). Cells were then fixed in methanol and stained with antibodies to tyrosine tubulin (3 and 4) or
P-actin (5 and 6) and FITC conjugated secondary antibodies. Panels 1 and 2 show phase contrast
images. Images were taken using a Zeiss LSM 510 scanning laser microscope. Images shown are




Figure 29: GnRH induced actin polymerisation is sensitive to the inhibition of Src family
kinases in SCL60 cells. Quiescent cells were pretreated with DMSO (1 and 2) or 5 |iM PP2 for
30 minutes (3 and 4). They were then treated with vehicle (1 and 3) or 100 nM GnRH (2 and 4)
for 30 minutes and fixed in methanol. Filamentous actin was stained with Alexafluor-568 labeled
phalloidin. Images were taken using a Zeiss LSM 510 scanning laser microscope. Images shown




































Figure 30: GnRH induces the activation of Src, associated with Triton X-100 insoluble
cytoskeletons in SCL60 cells. Quiescent cells were treated with vehicle or 100 nM GnRH for 10
minutes. Triton X-100 insoluble cytoskeletons were prepared and Src Tyr419 phosphorylation
analysed by Western blotting. GnRH induced a significant increase in Src Tyr419
phosphorylation compared to the unstimulated control (*, P<0.01 by Student's T-test). Data
represent the mean of three separate experiments + SEM.
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Discussion
The results presented within this chapter suggest a role for the non-receptor tyrosine
kinases FAK and Src in the activation of ERK 1 and 2 by the GnRH receptor in SCL60
cells. In this cell line, FAK was found to function as a molecular scaffold for recruitment
of key components of this pathway at focal contacts. This function was critically
dependent on its kinase activity and association with, and tyrosine phosphorylation by
Src as over expression of FAK point mutants that were kinase dead or unable to bind the
SH2 domains of Src or Grb2 all significantly inhibited ERK2 activation (Figure 15).
These findings demonstrate the important role of tyrosine phosphorylation and protein-
protein interactions mediated by SH2 domains in this process.
While FAK has previously been shown to form a complex with Src (Eide et al., 1995;
Thomas et al., 1998), this is the first report of an interaction between FAK and ERK2 in
vivo. This interaction may be physiologically important as it provides a mechanism of
targeting ERK2 to focal contacts where it may be activated, and may also tether the
active protein at the plasma membrane, thereby inhibiting nuclear translocation. Thus, the
interaction of FAK and ERK2 may provide a potential explanation for why GnRH is less
potent at stimulating ERK nuclear translocation compared to EGF (Figure 13).
Alternatively, when ERK 1 and 2 are activated by FAK at focal contacts, they may be
spatially constrained in the cytoplasm through interactions with additional proteins.
Recently, PEA-15 has been shown to regulate ERK 1 and 2 by sequestering them in the
cytoplasm, thereby preventing nuclear translocation and phosphorylation of nuclear
substrates (Formstecher et al., 2001). In contrast, PEA-15 does not appear to inhibit the
phosphorylation of substrates in the cytoplasm, including the serine/threonine kinase
RSK (Formstecher et al., 2001), which is an important downstream regulator of ERK
dependent signalling (Frodin and Gammeltoft, 1999). As PEA-15 has previously been
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shown to regulate integrin-dependent signalling (Ramos et al., 1998), such an interaction
seems plausible.
Though ERK 1 and 2 do not contain any modular protein-interaction domains, they
interact with their substrates and regulatory molecules in a highly specific manner.
Several short peptide motifs have recently been identified in these proteins that mediate
these interactions. The ERK binding motifs present in MEK 1 and 2 consists of a cluster
of basic amino acids surrounded by hydrophobic amino acids (Tanoue and Nishida,
2003). The docking site for this motif has recently been identified in ERK2 and features
two aspartate residues that are thought to make electrostatic interactions with the basic
amino acids (Tanoue et al, 2000). The crystal structure of ERK2 (Canagarajah et al.,
1997) shows that these aspartate residues are situated on the surface of the molecule and
thus are available to form intermolecular interactions. The ERK binding motifs present in
KSR and the transcription factors Elk-l and SAP-1 consist of a conserved F-X-F-P motif,
where X represent any amino acid (Jacobs et al., 1999a; Fantz et al., 2001). The
phenylalanine residues within this motif are thought to mediate hydrophobic interactions
with ERK. Although the binding site for this motif has not been identified in ERK, it is
tought to comprise a hydrophobic patch on the surface of the molecule (Tanoue and
Nishida, 2003). In C. elegans, gain of function mutants of lin-1, a transcription factor that
is negatively regulated by the nematode homologue of ERK, have been identified in
which the F-X-F-P motif is mutated, indicating that it plays a physiologically important
role in kinase-substrate interactions (Jacobs et al., 1999b). Recently, a third ERK binding
motif has been identified in the transcription factors Ets-1 and Ets-2. This motif consists
of a cluster of basic residues followed by a conserved L-X-L motif and a hydrophobic
triplet (Seidel and Graves, 2002). Examination of the amino acid sequence of FAK
identified a similar sequence D-R-K-G-M-L-Q-L-K-I-A-G-A-P-E, consisting of two
basic amino acids, an LXL motif, and a stretch of hydrophobic residues. This putative
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ERK binding site may therefore represent the site of interaction between FAK and ERK2,
however, this remains to be investigated. A number of experimental approaches could be
used to test whether this sequence represents the site of interaction between these two
proteins, including the yeast two-hybrid system, which has proven to be a very powerful
and sensitive tool for exploring protein-protein interactions in vivo. Because the crystal
structure of FAK has not been solved, it is currently unknown whether this motif is
situated on the surface of the molecule, where it could participate in molecular
interactions.
By using a range of pharmacological inhibitors FAK tyrosine phosphorylation was found
to be independent of PLC, PKC, and intracellular Ca2+, but required an intact actin
cytoskeleton and cell adhesion to the extracellular matrix (Figures 16 and 19). These
findings are in accordance with previous studies of FAK activation by bombesin, which
has been shown to be mediated by members of the Rho family GTPases (Sinnet-Smith et
al., 1993; Rozengurt, 1998). In SCL60 cells, Racl was found to be required for FAK
activation by GnRH (Figure 22). Furthermore, Toxin B (which inactivates RhoA, Racl
and Cdc42) was found to inhibit GnRH induced FAK phosphorylation (Figure 22). Toxin
B was also found to significantly reduce basal levels of FAK phosphorylation in these
cells, consistent with the role of the Rho family GTPases in the control of the actin
cytoskeleton and the formation and turnover of focal contacts (Nobes and Hall 1995;
Hotchin and Hall, 1995).
The first evidence that the Rho family GTPases were involved in the activation of FAK
by Gq coupled receptors was provided by Rankin et al. (1994), who showed that the
microinjection of Swiss 3T3 cells with C3 exoenzyme, which ADP-ribosylates and
inactivates RhoA, could inhibit FAK tyrosine phosphorylation by bombesin. Subsequent
studies have shown that constitutively active mutant forms of Gaq and Gal 1 can activate
RhoA and induce the formation of stress fibres in Swiss 3T3 cells and mouse embryo
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fibroblasts (Dutt et al., 2002; Vogt et al., 2003), thereby providing a direct link between
Gq/11 coupled receptors and the regulation of Rho activity. Gaq has been found to
activate the Rho specific guanine nucleotide exchange factors pll5RhoGEF, PDZ-
RhoGEF and LARG (Chikumi et al., 2002), which contain an RGS domain that mediates
their association with G-proteins. In mouse embryo fibroblasts, expression of a dominant
negative mutant of LARG inhibits RhoA activation and the formation of stress fibres by
several Gq coupled receptors (Vogt et al., 2003). These studies therefore provide a
mechanism whereby RhoA can be activated by Gaq. However, constitutively active
mutants of Gaq have not been reported to stimulate Racl activation or the formation of
lamellipodia.
Racl activation by several receptor tyrosine kinases, including the PDGF and insulin
receptors, is mediated by PI-3 kinase (Nobes et al., 1995). However, Racl activation by
GnRH was not blocked by the PI-3 kinase inhibitor wortmannin in SCL60 cells (Figure
27). Similarly, Racl activation by bombesin is insensitive to wortmannin (Nobes et al.,
1995), indicating that Gq coupled receptors may use a PI-3 kinase independent
mechanism to activate Racl. Data presented within this chapter demonstrate that Src
plays a critical role in this pathway (Figures 27 and 29). Furthermore, Src was found to
be present in Triton X-100 insoluble cytoskeleton extracts, where it is positioned to
participate in the regulation of the cortical actin cytoskeleton (Figure 30).
Recent studies have shown that Src can regulate Rac activity by phosphorylating the
guanine nucleotide exchange factors Ras-GRFl, Vavl, Vav2 and Tiaml. Ras-GRFl was
originally identified as a guanine nucleotide exchange factor for Ras that is activated by
Ca2+ influx (Farnsworth et al., 1995). In addition, to possessing a Cdc25 homology
domain that is responsible for Ras GDP/GTP exchange activity, Ras-GRFl contains a
double homology (DH) domain that is responsible for catalysing the exchange of GDP
for GTP by the Rho family GTPases (Kiyono et al., 1999). In vitro and in vivo studies
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have shown that Ras-GRFl is specific for Racl, and that its Rac GDP/GTP exchange
activity requires tyrosine phosphorylation by Src family kinases (Kiyono et al., 1999;
Kiyono et al., 2000). In contrast, the Ras GDP/GTP exchange activity of the protein is
unaffected by tyrosine phosphorylation (Kiyono et al., 1999). However, as Ras-GRFl
expression is restricted to the brain it is unlikely to be the guanine nucleotide exchange
factor that is activated by GnRH in SCL60 cells.
The Vav proteins comprise a small family of Rac specific guanine nucleotide exchange
factors that share a modular structure consisting of a calponin homology (CH) domain
that binds actin, a DH domain that is responsible for guanine nucleotide exchange
activity, a PH domain, two SH3 domains and an SH2 domain. While Vavl is expressed
exclusively in haematopoietic cells, Vav2 is ubiquitously expressed (Adams et al., 1992;
Schuebel et al., 1996). In quiescent cells Vavl and Vav2 maintained in an inactive
conformation through intramolecular interactions involving the DH and PH domains.
Tyrosine phosphorylation of these proteins by Src family kinases disrupts this inhibitory
intramolecular interaction and allows the DH domain to bind and activate Racl (Crespo
et al., 1997; Han et al., 1997).
Tiaml is a Rac specific guanine nucleotide exchange factor that was originally identified
in a retroviral insertional mutagenesis screen for genes that conferred an invasive
phenotype to T-lymphoma cells (Habets et al., 1994). It is a widely expressed protein
with a modular structure consisting of two PEST domains, two PH domains, a coiled-coil
region, a PDZ domain, and a DH domain. In quiescent cells, Tiaml is maintained in an
inactive conformation by intramolecular interactions involving the N-terminus of the
protein (Mertens et al., 2003). Like Vavl and Vav2, tyrosine phosphorylation of Tiaml
by Src disrupts this inhibitory intramolecular interaction, leading to an increase in its
nucleotide exchange activity (Servitja et al., 2003).
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As Vav2 and Tiaml are widely expressed proteins and are found in lysates from many
cell types, including HEK293 cells (Servitja el al., 2003), they represents good potential
candidates for the Racl specific guanine nucleotide exchange factor regulated by GnRH
in SCL60 cells. To investigate this, immune precipitation and Western blotting studies
could be performed to determine if Vav2 or Tiaml are tyrosine phosphorylated by Src in
SCL60 cells following stimulation with GnRH. Because specific pharmacological
inhibitors are not commercially available for these proteins, RNAi could then be used to
study their role in GnRH receptor signalling.
Further evidence for a role of Src in the activation of Racl has been provided by studies
of cells transformed with the oncogene v-Src. When cells are transformed with this
oncogene they become able to grow independently of anchorage in soft agar. The
colonies that are formed are morphologically very similar to those seen when cells are
transformed with activated mutants of the Rho family GTPases or their guanine
nucleotide exchange factors (Servitja et al., 2003). Furthermore, when cells are
transformed with v-Src and a dominant negative form of Racl (N17Racl), the number of
colonies formed is significantly reduced (Servitja et al., 2003). These results therefore
suggest that Racl is an integral component of the signalling pathway used by v-Src and
by inference, its cellular homologue.
The studies of Src activation using phosphospecific antibodies shown within this chapter
suggest that Src may be initially activated by the dephosphorylation of pTyr530 (Figure
12), indicating that GnRH activates a protein tyrosine phosphatase in SCL60 cells.
Perhaps the best candidate molecule for this GnRH regulated phosphatase is PTPa,
which is widely expressed, localises to focal contacts and co-immune precipitates with
Src and Fyn in vivo (Harder et al., 1998; Bhandari et al., 1998). However, the mechanism
of activation of PTPa by extracellular signalling molecules such as GnRH remains poorly
understood. Though protein kinases are known to be important molecules in GnRH
119
receptor signalling, protein phosphatases have received much less attention. Nevertheless,
these experiments indicate that a protein tyrosine phosphatase plays a key role in the
activation of Src by GnRH. This could be further investigated by using protein tyrosine
phosphatase inhibitors such as pervanadate or hydrogen peroxide. Because isoform-
specific pharmacological inhibitors are not currently available for these proteins, RNA
interference (RNAi) could also provide a useful tool for studying the role of individual
phosphatases in GnRH receptor signalling.
Though pTyr530 is only transiently dephosphorylated following stimulation of SCL60
cells with GnRH, Tyr419 autophosphorylation and Src kinase activity remained elevated
above basal levels for 1 hour (Figure 12). These findings are in accordance with a
previous study by Boerner et al. (1996), who showed that Src retains significant enzyme
activity when doubly phosphorylated at Tyr530 and Tyr419. Examination of the crystal
structures of the active and inactive forms of the enzyme provides clues to how this may
occur. In the inactive state, the activation loop adopts an ordered helical structure and
Tyr419 is sequestered in a hydrophobic pocket where it helps stabilise the closed
(inactive) conformation of the catalytic domain (Xu et al., 1999). However, when it is
phosphorylated, Tyr419 cannot be accommodated in this hydrophobic pocket and
therefore cannot help fix the N- and C-terminal lobes of the catalytic domain in the closed
conformation (Xu et al., 1999), even when the SH2 domain binds pTyr529. Thus the
catalytic domain can remain active. Therefore the inactivation of Src requires both the
phosphorylation of Tyr530 by Csk, and the dephosphorylation of Tyr419 by an unknown
protein tyrosine phosphatase. Src may also be active when doubly phosphorylated at
Tyr530 and Tyr419 when bound to FAK via its SH2 and SH3 domains, which relieves
the intramolecular repression of the catalytic domain. Both these situations may occur in
SCL60 cells, accounting for the prolonged activation of Src.
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These observations also suggest that Src activation in SCL60 cells may reflect two
distinct events that are temporally and mechanistically distinct. Src may be initially
activated by the transient dephosphorylation of pTyr530 by a protein tyrosine
phosphatase, and subsequently by interactions with FAK. Thus, Src activation may occur
upstream (protein tyrosine phosphatase dependent) and downstream (FAK dependent) of
Racl activation. Therefore, it would be expected that the initial activation of Src by
GnRH would occur independently of Rho family GTPases, while at later time points it
would be predicted to be sensitive to the inhibition of Rho family GTPases (which are
required for the activation of FAK). Indeed, Src Tyr419 autophosphorylation was found
to be inhibited by C. difficile toxin B at 10 minutes (Figure 22), however, it is unknown
what effect this compound has on Src pTyr529 dephosphorylation at earlier time points.
Based on these observations, a model of ERK activation may be proposed in which
GnRH activates a protein tyrosine phosphatase, which dephosphorylates the regulatory
tyrosine residue in the C-terminal tail of Src leading to its activation. Src then
phosphorylates a Racl specific guanine nucleotide exchange factor, perhaps Vav2 or
Tiaml, leading to the activation of Racl, Scar and the Arp2/3 complex, which initiates
actin polymerisation at the cell cortex. Once nucleated, actin filaments grow rapidly
towards the plasma membrane, providing the protrusive force that is required for the
extension of lamellipodia. Integrins become aggregated in lamellipodia, forming focal
complexes, which provide anchor points for the cell as it moves. Integrin aggregation in
turn leads to the oligomerisation and activation of FAK, which /ra«.v-autophosphorylates
at Tyr397 to create a binding site for Src. Thus, Src is recruited into a complex with FAK,
which stabilises it in an active conformation. Src then phosphorylates FAK on a number
of tyrosine residues, including Tyr925, which creates a binding site for the SH2 domain
ofGrb2. Grb2 then recruits Sos to the plasma membrane where it activates Ras to initiate
the activation of the ERK cascade.
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In accordance with this model, ERK activation was found to be dependent on cell
adhesion to the extracellular matrix, required an intact actin cytoskeleton and FAK, Src
and Racl activity (Figures 18, 21 and 22). In addition, ERK activation was also found to
be sensitive to inhibitors of PKC (Figure 18), indicating that multiple signals converge to
provide precise regulation of this pathway. Although the results presented within this
chapter indicate that PKC plays only a minor role in ERK activation, this may reflect the
fact that low concentrations of both PKC inhibitors were used in these studies, which
may not have been sufficient to completely block cellular PKC. Therefore, the role of
PKC in the activation of the ERK signalling cascade may have been under represented in
these cells. However, as ERK activation was not inhibited by BAPTA-AM, which
chelates intracellular Ca2+, conventional PKC isozymes do not appear to be involved.
These findings are in accordance with a study in LPT2 cells, which showed ERK
activation by GnRH to require PKC but to be independent of Ca2+ (Liu et ai, 2002).
Because inhibition of PLC did not significantly inhibit ERK activation by GnRH (Figure
18), it may be speculated that an atypical PKC may be involved in this pathway, as they
do not require diacylglycerol or Ca2+ for their activation (Newton, 1997). However,
activation of a novel PKC isozyme cannot be discounted as PLC activity was not
completely inhibited by U73122 in SCL60, even when used at concentrations up to 20
pM (Figure 24). Therefore, sufficient diacylglycerol may have been generated by PLC
mediated hydrolysis of PtdIns(4,5)P2 in the presence ofU73122 to activate these kinases.
By using RNAi to knockout the expression of specific PKC isozymes, it may be possible
to identify those isozymes involved in the activation of ERK in SCL60 cells, however,
this was beyond the scope of this thesis.
Future work
To gain a better understanding of the role played by tyrosine kinases such as FAK and
Src in GnRH receptor signalling, it would be desirable to identify the three other proteins
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that were tyrosine phosphorylated following stimulation of SCL60 cells with GnRH
(Figure 10). Potential candidate molecules for these phosphoproteins include Vav2 and
paxillin, which have molecular weights of 101 KDa and 68 KDa, respectively. Paxillin is
the prototypic member of a family of scaffolding proteins, which also includes hic-5 and
leupaxin (Schaller, 2001). These proteins contain a number of modular protein-
interaction domains, which control their subcellular localisation and interaction with
other proteins. The C-terminus of paxillin contains four Lin-11, Isl-1, Mec-3 (LIM)
domains (Schmiechel and Beckerle, 1994), which are responsible for targeting it to focal
contacts (Brown et al. 1996), while the N-terminus contains multiple copies of another
interaction domain called the LD motif, which features the consensus sequence L-D-X-L-
L-X-X-L, where X represents any amino acid (Brown et al., 1996). The LD motif is
predicted to form a a-helix with the leucine residues lying along one side, presenting a
hydrophobic protein-binding surface (Turner, 2000). The individual LD motifs ofpaxillin
have been shown to bind a number of different proteins and have discrete binding
preferences. LD1, LD2 and LD4 bind the structural protein vinculin, while LD2 and LD4
bind FAK (Brown et al., 1996; Turner, 2000).
The N-terminus of paxillin also contains two important tyrosine residues, Tyr31 and
Tyrll8, which are phosphorylated by Src and FAK (Schaller and Parsons, 1995).
Phosphorylation of these residues creates binding sites for the SH2 domains of the
adapter protein Crk (Schaller and Parsons, 1995), which is involved in the control of
integrin mediated cell motility, and Csk (Sabe et al., 1994) which plays an important role
in controlling Src activity by phosphorylating Tyr530 as described (Nada et al., 1991).
The structure of Csk is very similar to the Src family kinases, consisting of a conserved
catalytic domain, an SH2 domain and an SH3 domain (Ogawa et al., 2002). However,
unlike the majority of other protein kinases, Csk has a high basal level of enzyme
activity, and is not regulated by phosphorylation of residues within its activation loop
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(Lamers et al., 1999). Rather, Csk appears to be regulated through the control of its
subcellular localisation and thus access to potential substrates. Therefore, recruitment of
Csk into focal contacts through its association with tyrosine phosphorylated paxillin may
bring it into proximity to Src, allowing it to phosphorylate Tyr530. Thus, paxillin tyrosine
phosphorylation may play a role in the control ofGnRH receptor signalling by recruiting
proteins to the plasma membrane that are involved in the regulation of Src activity, and
the organisation of the actin cytoskeleton. Thus, identification of the remaining
phosphoproteins may help provide a more complete understanding of the role of protein
tyrosine phosphorylation in the regulation of GnRH receptor signalling, and may provide
new avenues for future research.
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Identification of Src binding proteins involved in
the regulation ofGnRH receptor signalling
Introduction
Many signalling pathways in eukaryotic cells are regulated by the reversible assembly of
multi-protein complexes that integrate and transmit signals from cell surface receptors to
the cytoplasm and nucleus. The assembly of these complexes is regulated by a variety of
protein- and lipid-interaction domains that target proteins to specific subcellular
localisations and mediate molecular interactions (Yaffe and Elia, 2001; Pawson and Nash
2003). Proteomic techniques offer a new, unbiased approach for studying the assembly of
these protein complexes during signal transduction.
The combination of two-dimensional gel electrophoresis and MALDI-ToF mass
spectrometry is one of the most commonly used methods in proteomics, and has become
the analytical tool of choice for many researchers. These techniques allow rapid
separation and identification of many cellular proteins and are applicable to high
throughput screening. Protein identification has been greatly facilitated by the sequencing
of the human and mouse genomes, and by the provision of detailed protein databases on
the worldwide web that can be searched using user friendly software such as MS-Fit
(http://prospcetor.ucsf.edu) to generate peptide mass fingerprints.
Having established a role for Src in the activation of the ERK cascade, a proteomics
study was undertaken to identify novel Src binding proteins that may be involved in the
regulation of GnRH receptor signalling. Src is an ideal molecule for such a study because
it contains SH2 and SH3 domains that mediate interactions with its substrates, and
specific antibodies are available for immune precipitation, which allows simple
purification of Src complexes. In this chapter, the identification of DGKTJ as a Src




Two-dimensional gel electrophoresis and silver staining revealed that Src associates with
many proteins in quiescent SCL60 cells. However, 20 different proteins were found to
co-precipitate with Src only after stimulation with GnRH (Figure 31). These proteins
were cut from the gel, digested with trypsin, and analysed by MALDI-ToF mass
spectrometry. In two separate experiments, good data sets were obtained for protein
number three, which had an apparent molecular weight of 100 KDa and an isoelectric
point of pH 8.5 (Figure 31). One of the mass spectra obtained for this protein is shown in
Figure 32. Peptide mass fingerprinting identified this protein as the lipid kinase
DGKC (Figure 33), with molecular weight search (MOWSE) scores of 6.45 xlO6 and
6.172 xlO6 being reported. A numer of keratins were also found to be present in the
sample, namely cytokeratin 1 (MOWSE score 1.129 x 106), cytokeratin 2e (MOWSE
score 1.082 x 106), cytokeratin 5 (MOWSE score 3.467 x 10s) and cytokeratin 9
(MOWSE score 4.609 x 106). As these proteins have molecular weights in the region of
60 - 70 KDa they probably do not represent proteins co-precipitating with Src but rather
contaminants from skin when handling the gel.
The other proteins analysed by MALDI-ToF mass spectrometry could not be identified
with any confidence. The low success rate of protein identification may reflect the low
abundance of proteins in the sample, which approached the limit of detection by silver
staining and the mass spectrometer, and was further hampered by keratin contamination
of the gel, which proved to be a major problem.
In the human, alternative splicing of the DGK^ gene gives rise to two isoforms of the
protein with predicted molecular weights of 104 KDa (Accession number: Q13374-2)
and 124 KD (Accession number: Q13374-1), respectively. The mass of the protein
estimated from the two-dimensional gel would suggest that it is the 104KDa isoform that
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co-precipitates with Src in these cells. Analysis of the amino acid sequence of DGK£,
using scansite (http://scansite.mit.edu) identified a potential Src phosphorylation site at
Tyr558 (Y*-L-E-V) and two proline rich motifs that may be ligands for the SH3 domain
of Src. The sequences of these proline rich regions are L-A-P-P-P-P-T-P-G-A-P (amino
acids 65 - 75) and D-L-P-T-P-T-S-P-L-P-T (amino acids 762 - 772). All three motifs are
conserved in rat and mouse DGK^, and may therefore represent the site(s) of interaction
between the two proteins.
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Figure32:MALDI-ToFmassspectrum.Thesobtainedf proteinnumber,whichhadnp ar ntm lec laeighfproximat ly100KD andisoelectricpointfH8.5.
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MEPRDGSPEA RSSDSESASA SSSGSERDAG PEPDKAPRRL NKRRFPGLRL
FGHRKAITKS GLQHLAPPPP TPGAPCSESE RQIRSTVDWS ESATYGEHIW
FETNVSGDFC YVGEQYCVAR MLKSVSRRKC AACKIWHTP CIEQLEKINF
RCKPSFRESG SRNVREPTFV RHHWVHRRRQ DGKCRHCGKG FQQKFTFHSK
EIVAISCSWC KQAYHSKVSC FMLQQIEEPC SLGVHAAWI PPTWILRARR
PQNTLKASKK KKRASFKRKS SKKGPEEGRW RPFIIRPTPS PLMKPLLVFV
NPKSGGNQGA KIIQSFLWYL NPRQVFDLSQ GGPKEALEMY RKVHNLRILA
CGGDGTVGWI LSTLDQLRLK PPPPVAILPL GTGNDLARTL NWGGGYTDEP
VSKILSHVEE GNWQLDRWD LHAEPNPEAG PEDRDEGATD RLPLDVFNNY
FSLGFDAHVT LEFHESREAN PEKFNSRFRN KMFYAGTAFS DFLMGSSKDL
AKHIRWCDG MDLTPKIQDL KPQCWFLNI PRYCAGTMPW GHPGEHHDFE
PQRHDDGYLE VIGFTMTSLA ALQVGGHGER LTQCREWLT TSKAIPVQVD
GEPCKLAASR IRIALRNQAT MVQKAKRRSA APLHSDQQPV PEQLRIQVSR
VSMHDYEALH YDKEQLKEAS VPLGTVWPG DSDLELCRAH IERLQQEPDG
AGAKSPTCQK LSPKWCFLDA TTASRFYRID RAQEHLNYVT EIAQDEIYIL
DPELLGASAR PDLPTPTSPL PTSPCSPTPR SLQGDAAPPQ GEELIEAAKR
NDFCKLQELH RAGGDLMHRD EQSRTLLHHA VSTGSKDWR YLLDHAPPEI
LDAVEENGET CLHQAAALGQ RTICHYIVEA GASLMKTDQQ GDTPRQRAEK
AQDTELAAYL ENRQHYQMIQ REDQETAV
Figure 33: Peptide mass fingerprinting of human DGK£. Peptides identified by MALDI-ToF
mass spectrometry are highlighted in red. Peptide coverage was approximately 14%.
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The expression of DGKj^ in SCL60 cells was confirmed by immune precipitation and
Western blotting using a polyclonal antibody that was specific for the 104 KDa isoform
of the enzyme. A protein of approximately 100 KDa was identified in cytoplasmic
extracts, that was not detected when immune precipitations were performed with pre-
immune serum (Figure 34 A). The interaction between Src and DGKtJ was also
confirmed by immune precipitation and Western blotting. Src was found to co-precipitate
with DGK^ only following stimulation with GnRH (Figure 34 B). Src was also found to
bind to DGK^ in vitro by affinity chromatography, using immobilised recombinant rat
DGK^ as ligand (Figure 35). Note the recombinant protein has a molecular weight of
approximately 130 KDa, due to the presence ofGST and 6 His tags at the N-terminus.
The association between Src and DGK^ was found to be dependent on Src enzyme
activity, as it could be significantly inhibited by the pre-treatment of cells with the
general tyrosine kinase inhibitor herbimycin A or the Src family kinase inhibitor PP2
(P<0.01) (Figure 34 B). Although Src enzyme activity was appeared to be required for
the association of the two proteins, DGK^ was not found to be tyrosine phosphorylated
following stimulation of SCL60 cells with GnRH, as determined by Western blotting
DGK^ immune precipitates with an anti-phosphotyrosine antibody (Figure 36).
In vitro kinases assays, performed with mixed micelles containing phosphatidylserine and
dioleoyl-sn-glycerol as substrate, revealed that GnRH stimulated the enzymatic activity
ofDGK£, that was immune precipitated from SCL60 cells (Figure 37). The activation of
DGK^ by GnRH appeared to require Src enzyme activity, as it could be inhibited by pre-
treating cells with PP2 (Figure 37). However, PP2 had no direct effect on DGK^ kinase
activity in vitro when added to immune precipitates for 30 minutes prior to performing
the kinase assay. Thus, these effects were not due to the direct inhibition of the catalytic
domain of DGK^ by this compound (data not shown). In many cells, the cytoskeleton
functions as a scaffold for enzymes involved in lipid metabolism. Immune precipitation
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and Western blotting revealed that DGK^ was associated with Triton X-100 insoluble
cytoskeletons in SCL60 cells (Figure 38 A), and in vitro kinases assays revealed that
GnRH activated the DGK^ that was associated with the cytoskeleton (Figure 38 B).
DGK^ was also found to be expressed in LPT2 gonadotroph cells (Figure 39). As the
enzyme activity of the DGKs has been shown to be controlled in part by regulating their
access to substrate in the plasma membrane, the effects of GnRH on the subcellular
localisation of GFP-tagged DGK^, was investigated in these cells by confocal
microscopy. In quiescent LPT2 cells, GFP-DGK^ was found to be present in the nucleus
and cytoplasm. However, following stimulation with GnRH, it was observed to
translocate to the plasma membrane (Figure 40). Membrane translocation was rapid,
occurring within 10 minutes of agonist treatment, and was found to be sensitive to the
inhibition of Src enzyme activity with PP2 (Figure 41). Membrane translocation also
required an intact actin cytoskeleton, as it could be abolished by pre-treatment of cells
with cytochlasin-D (Figure 42) or latrunculin-B (Figure 43), and required PKC activity

































Figure 34: Confirmation of DGK^ expression and association with Src in SCL60 cells. (A)
Cytoplasmic extracts were prepared and proteins immune precipitated with pre-immune serum
(lane 1) or anti-DGK^ (lane 2). Proteins were resolved by SDS-PAGE and DGK^ expression
analysed by Western blotting. (B) Quiescent cells were pre-treated with PP2 (5 pM, 30 minutes),
herbimicin A (100 nM 30 minutes) or DMSO. They were then treated with vehicle or 100 nM
GnRH for 10 minutes and cytoplasmic extracts prepared. DGK^ was immune precipitated and Src
association analysed by SDS-PAGE and Western blotting. Pretreatment of cells with herbimycin
A or PP2 significantly inhibited the GnRH induced association of Src with DGK(^ (*, P<0.01 by
ANOVA and Tukey's pairwise comparison). Data represent the mean of three separate
experiments + SEM.
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IB: a-DGKi^ IB: a-Src
12 12
Figure 35: Confirmation of Src-DGK^ association by DGK£ affinity chromatography. 6 His
tagged recombinant DGK^ was immobilised on Ni2+-NTA resin and incubated with buffer alone
(lane 1) or rat brain lysate (lane 2). Proteins were solubilised and Src association analysed by
































Figure 36: DGK£ is not tyrosine phosphorylated in SCL60 cells following stimulation with
GnRH. Quiescent cells were treated with vehicle or 100 nM GnRH for 10 minutes and
cytoplasmic extracts prepared. DGK^ was immune precipitated, and its tyrosine phosphorylation
status analysed by SDS-PAGE and Western blotting with an anti-phopshotyrosine antibody. The
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Figure 37: Src mediated activation of DGK£ by GnRH in SCL60 cells. Quiescent cells were
treated with DMSO or PP2 (5 pM, 30 min). They were then treated with vehicle or 100 nM
GnRH for 10 minutes and cytoplasmic extracts prepared. DGK^ was immune precipitated and
kinase activity assayed in vitro using [y-32P]ATP and 1,2-dioleoyl-in-glycerol as substrate.
Radiolabeled lipids were extracted, resolved by thin-layer chromatography, and visualised by








Figure 38: DGK^ is associated with Triton X-100 insoluble cytoskeletons in SCL60 cells. (A)
Proteins were immune precipitated from solubilised cytoskeletons with pre-immune serum (lane
1) or anti-DGK^ antibody (lane 2). Proteins were resolved by SDS-PAGE and the association of
DGK^ with the cytoskeleton analysed by Western blotting. The immunoblot shown is
representative of three separate experiments. (B) Quiescent cells were treated with vehicle or 100
nM GnRH for 10 minutes and cytoskeletal extracts prepared. DGK^ was immune precipitated and
kinase activity assayed in vitro using [y-32P]ATP and 1,2-dioleoyl-sn-glycerol as substrate.
Radiolabelled lipids were extracted, resolved by thin-layer chromatography and visualised by


















Figure 39: Expression of DGK^ in LPT2 cells. Cytoplasmic extracts were prepared from LPT2
cells and proteins immune precipitated with pre-immune semm (lane 1) or anti-DGKC antibody
(lane 2). Proteins were resolved by SDS-PAGE and DGKC expression analysed by Western
blotting. The immunoblot shown is representative of three separate experiments.
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Figure 40: GnRH stimulates the membrane translocation of GFP-DGK£ in LPT2 cells. 48
hours after transfection quiescent cells were stimulated with 100 nM GnRH. Images were before
treatment, (1) and at 2 minutes (2), 5 minutes (3), 10 minutes (4), 15 minutes (5) and 20 minutes
(6) after stimulation with GnRH, using a Zeiss LSM 510 laser scanning microscope. Images




Figure 41: Membrane translocation of GFP-DGK^ is sensitive to the inhibition of Src family
kinases in LpT2 cells. 48 hours after transfection quiescent cells were pretreated with PP2 (5 |iM,
30 minutes) then stimulated with 100 nM GnRH. Images were taken before treatment (1) and at 2
minutes (2), 5 minutes (3), 10 minutes (4), 15 minutes (5) and 20 minutes (6) after stimulation
with GnRH, using a Zeiss LSM 510 laser scanning microscope. Images shown are representative




Figure 42: Membrane translocation of GFP-DGK^ is sensitive to actin filament disruption
with cytochalasin-D in LPT2 cells. 48 hours after transfection quiescent cells were pretreated
with cytochalasin-D (1 |iM, 30 minutes) then stimulated with 100 nM GnRH. Images were taken
before treatment (1) and at 2 minutes (2), 5 minutes (3), 10 minutes (4), 15 minutes (5) and 20
minutes (6) after stimulation with GnRH, using a Zeiss LSM 510 laser scanning microscope.




Figure 43: Membrane translocation of GFP-DGK£ is sensitive to actin filament disruption
with latrunculin-B in LPT2 cells. 48 hours after transfection quiescent cells were pretreated with
latrunculin-B (1 pM, 30 minutes) then stimulated with 100 nM GnRH. Images were taken before
treatment (1) and at 2 minutes (2), 5 minutes (3), 10 minutes (4), 15 minutes (5) and 20 minutes
(6) after stimulation with GnRH, using a Zeiss LSM 510 laser scanning microscope. Images




Figure 44: Membrane translocation of GFP-DGK^ is sensitive to inhibition of PKC in L|3T2
cells. 48 hours after transfection quiescent cells were pretreated with Ro-318220 (100 nM, 30
minutes) then stimulated with 100 nM GnRH. Images were taken before treatment (1) and at 2
minutes (2), 5 minutes (3), 10 minutes (4), 15 minutes (5) and 20 minutes (6) after stimulation
with GnRH, using a Zeiss LSM 510 laser scanning microscope. Images shown are representative
of five separate experiments.
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Discussion
The results presented within this chapter provide evidence for the first time that Src
associates with the lipid kinase DGK^ following stimulation of SCL60 cells with GnRH.
Furthermore, this interaction was found to play a role in regulating DGK^ enzyme
activity and was required for it to translocate from the cytoplasm to the plasma membrane
where it interacts with its substrate.
The first evidence that Src may be involved in the regulation of diacylglycerol signalling
was provided by studies of fibroblasts transformed with the oncogene v-Src. Expression
of this oncogene was found to cause a significant increase in the cellular concentration of
phosphatidic acid, and a diacylglycerol kinase activity co-purified with v-Src (Sugimoto
et al., 1984). Subsequently, it has been shown that Src can associate with DGKa
following stimulation of cells with hepatocyte growth factor (HGF) (Cutrupi et al., 2000)
and that this interaction is required for HGF and vascular endothelial growth factor
(VEGF) to stimulate DGKa enzyme activity (Cutrupi et al., 2000; Baldanzi et al., 2004).
The association between Src and DGKa was also reported require Src kinase activity as it
could be abolished by pretreating cells with the Src family kinase inhibitor PP1, or by
over expressing a kinase dead point mutant of Src (Cutrupi et al., 2000). These findings
suggest that Src may regulate the activity of DGKa and DGKCj through a conserved
mechanism.
While DGKa contains three conserved tyrosine residues that are putative Src
phosphorylation sites, tyrosine phosphorylation could not be detected with endogenous
levels of protein without inhibiting protein tyrosine phosphatases with pervanadate
(Cutrupi et al., 2000). Phosphorylation of DGKa by Src appears to be transient and occur
at low stoichiometry, nevertheless, the tyrosine phosphorylated protein has high levels of
enzyme activity, indicating that tyrosine phosphorylation may still be an important event
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in its activation (Cutrupi et al., 2000). Therefore, Src mediated phosphorylation of DGK^
may also be a transient event, which may explain why it could not be detected by
immune precipitation and Western blotting. Furthermore, if Src phosphorylates DGK^ at
low stoichiometry, a more sensitive means of detection may be required. Alternatively,
protein tyrosine phosphatases may need to be inhibited if tyrosine phosphorylation is to
be detected. By mutating the putative Src phosphorylation site in DGK£, (Tyr558) to
alanine it may be possible to determine if Src mediated tyrosine phosphorylation of this
residue is required for its DGK^ by GnRH. Conversely, substitution of this residue with
the phosphomimetic amino acid aspartic acid may lead to constitutive enzyme activity.
Activation of the DGKs also requires that they translocate from the cytoplasm to the
plasma membrane where they interact with their substrate. A recent study by Santos et al.
(2002) has provided many details of the mechanism whereby DGK^ is recruited to the
plasma membrane following the activation of Gq coupled receptors. GFP-tagged
DGK^ rapidly translocates to the membrane following the activation of the type I
muscarinic receptor with carbachol, when expressed in Jurkat cells. Membrane
recruitment was found to be independent of DGK^ enzyme activity, but required serine
phosphorylation by PKC (Santos et al., 2002). DGK^ contains anl8 amino acid motif (K-
A-S*-K-K-K-K-R-A-S*-F-K-R-K-S*-S*-K-K) that is very similar to the PKC
phosphorylation motif of the myristoylated alanine rich C kinase substrate (MARCKS)
protein (Bunting et al., 1996). Pharmacological inhibition of PKC, or mutation of the
serine residues within this MARCKS homology domain to alanine prevented enzyme
activation and membrane translocation of DGK^ in response to carbachol. When the
serine residues within this motif were substituted with aspartic acid, DGK^ retained the
ability to translocate to the plasma membrane. However, it was not found to be
constitutively associated with the membrane, indicating that phosphorylation of the
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MARCKS homology domain by PKC is necessary but not sufficient for membrane
recruitment (Santos et al., 2002).
MARCKS homology domains are found in a number of proteins that shuttle between the
cytoplasm and the plasma membrane. In the MARCKS protein, the basic residues in this
motif mediate electrostatic interactions with acidic phospholipids in the membrane
(Arbuzova et al., 1997; Bahr et al., 1998). Phosphorylation of the serine residues
dramatically alters the electrostatic potential of the domain, reducing its affinity for
membranes, which causes the protein to become cytoplasmic (Kim et al., 1994a; Kim et
al., 1994b). However, phosphorylation of the serine residues within the MARCKS
homology domain of DGK^ appears to have the opposite effect as it is required for
membrane translocation. It has been proposed that phosphorylation of these residues may
facilitate membrane recruitment of DGK^ by causing a conformational change in the
molecule that alters its association with regulatory proteins (Santos et al., 2002).
Alternatively, the MARCKS homology domain may make electrostatic contacts with an
acidic patch on DGK^ that maintains it in an inactive conformation and prevents
interactions with substrate or regulatory molecules until it is phosphorylated by PKC.
Santos et al. (2002) also demonstrated that both CI domains are required for enzyme
activity and membrane recruitment of DGK^. Mutation of the two conserved histidine
residues required for the co-ordination of Zn2+ in either of the CI domains to glycine
abolished enzyme activity and membrane recruitment in response to carbachol (Santos et
al., 2002).
The results presented within this chapter provide further details of the mechanism of
DGK^ membrane recruitment following the activation of Gq coupled receptors. In
addition to phosphorylation of serine residues within the MARCKS homology domain,
and the CI domains, which are thought to bind diacylglycerol, membrane translocation
appears to require an intact actin cytoskeleton and Src activity. The role of Src-mediated
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tyrosine phosphorylation in this process could be investigated by mutating the putative
Src phosphorylation site (Tyr558) to phenylalanine and aspartic acid. If tyrosine
phosphorylation of this residue by Src is a prerequisite for membrane recruitment
substitution with phenylalanine would be predicted to abolish it, while substitution with
aspartic acid should facilitate it. Alternatively, DGK^ may be recruited to the plasma
membrane in association with an additional protein that is activated by Src, or by binding
to the SH3 domain of Src, which is itself targeted to the plasma membrane via N-terminal
myristoylation. This latter point could tested by creating deletion mutants of DGKC,
lacking the proline rich regions that were identified as potential ligands for the SH3
domain of Src.
By phosphorylating diacylglycerol to produce phosphatidic acid, the diacylglycerol
kinases may play an important role in regulating the activity of the conventional and
novel PKC isozymes. Thus the results presented in this chapter provide a mechanism for
the feedback regulation of PKC activation by GnRH. In addition, phosphatidic acid plays
a number of roles in the cell. It is an important intermediate in the synthesis of
phosphatidylinositol, and also has second messenger functions. Perhaps the best evidence
for the essential role of diacylglycerol kinases in phosphatidylinositol biosynthesis has
been provided by studies of retinal degeneration mutants in D. melanogaster. In the rdgA
mutant, photoreceptor cells differentiate normally but degenerate rapidly after eclosion
(Hotta and Benzer, 1970). Their degeneration starts with the breakdown of the
subrhabdomeric cistemae, which is the specialised smooth endoplasmic reticulum that
forms immediately beneath the rhabdomeric microvilli in the compound eye (Matsumoto
et al., 1988; Matsumoto-Suzuki et al., 1989; Masai et al., 1997). Biochemically, the rdgA
mutant lacks an eye specific diaclyglycerol kinase in a gene dosage-dependent manner
(Inoue et al., 1989). Cloning of the rdgA gene showed that it encoded a diacyglycerol
kinase, designated DGK2, that is expressed exclusively in the compound eye (Masai et
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al., 1993; Massai et al., 1997). The Drosophila DGK2 contains a catalytic domain that is
conserved with the mammalian diacylglycerol kinases, two CI domains and four tandem
ankyrin repeats (Masai et al., 1993), and therefore is very similar in structure to the
mammalian type IV DGKs, which includes DGK^ (Figure 9). In the retina, DGK2 is
found almost exclusively in association with the membranes of the subrhabdomeric
cisternae, where diacylglycerol is converted to phosphatidic acid. In the rdgA mutant, it is
thought that the lack of phosphatidic acid in the subrhabdomeric cistemae leads to its
breakdown and results in an insufficient supply of phosphatydlinositol to the
photoreceptive membrane, which is essential for the maintenance of the photoreceptors as
well as for phototransduction (Masai et al., 1997).
Phosphatidic acid is also recognised to play a role in the regulation of the ERK signalling
cascade (Andresen et al., 2002), and has been shown to bind Raf-1 in vitro (Ghosh et al.,
1996). Mutational analysis has determined that the phosphatidic acid binding site in Raf-
1 is contained within a 35 amino acid polybasic motif that is adjacent to the catalytic
domain (Ghosh et al., 1996). Mutation of a single arginine residue (Arg398) within this
polybasic motif to alanine is sufficient to reduce the affinity of the mutant protein for
phosphatidic acid, to impair membrane binding, and inhibit ERK activation by
extracellular signalling molecules (Rizzo et al., 1999). It is now thought that phosphatidic
acid binding rather than Ras binding drives the plasma membrane translocation of Raf-1
(Rizzo et al., 1999). A putative polybasic phosphatidic acid binding motif has also been
identified in the ERK scaffolding protein KSR (Figure 45), indicating that phosphatidic
acid may also recruit this protein to the plasma membrane to facilitate the assembly of the
kinases of the ERK cascade into a cohesive signalling module. Thus, activation of DGKd^
by GnRH may also contribute to the activation of ERK 1 and 2. Because the currently
available diacylglycerol kinase inhibitors do not affect DGK<^ activity, RNAi could be




Figure 45: The phosphatidic acid binding domains of Raf-1 (amino acids 390 - 426) and
KSR (amino acids 497 - 533).
Phosphatidic acid has also been shown to stimulate the activity of PIP-5 kinase, which
phosphorylates PtdIns(4)P to produce PtdIns(4,5)P2 (Ishihara et al., 1996). Although
PtdIns(4,5)P2 represents less than 1% of total membrane phospholipids it has a pivotal
role in numerous signalling events (Toker, 1998). It is hydrolysed by PLC to generate
diacylglycerol and Ins(l,4,5)P3 as described previously, and is phosphorylated by PI-3
kinase to produce PtdIns(3,4,5)P3. In addition PtdIns(4,5)P2 regulates the activity ofmany
proteins involved in the regulation of the actin cytoskeleton (Sechi and Wehland, 2000).
Recently, PIP5Ia has been shown to bind to DGK^, and both proteins co-localise in
lamellipodia in migrating cells (Lou et al., 2004b), where they are positioned to
participate in the regulation of the cortical actin cytoskeleton. Thus, DGK^ may also be
involved in the regulation of the actin cytoskeleton in SCL60 cells by activating PIP-5Ia
kinase.
Future work
Although the data presented within this chapter show that Src interacts with DGK^
following stimulation of SCL60 cells with GnRH, many of the molecular details
regarding this interaction remain unknown. By using techniques such as the yeast-two
hybrid screen, it may be possible identify which domains in Src are important for this
interaction. However, it is also possible that the interaction between these proteins is not
direct but mediated by an additional protein in a putative complex with Src. Improved
proteomic techniques such as tandem affinity purification may therefore help to solve this
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problem by reducing the number of non-specific proteins co-precipitating with Src during
immune precipitation and allowing a more detailed analysis of Src complexes.
By using purified proteins, it may be possible to show Src mediated phosphorylation of
DGK^ in vitro and allow the phosphorylation sites to be mapped. Such studies would
undoubtedly shed light on the mechanism ofDGK<^ activation by Src.
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Conclusion
Protein phosphorylation on serine, threonine and tyrosine residues plays an important role
in GnRH receptor signalling, regulating the activity of protein and lipid kinases and
creating binding sites for protein-interaction domains to nucleate the formation of
signalling complexes. The non-receptor tyrosine kinase Src appears to play a central role
in GnRH receptor signalling and is intimately involved in numerous processes, including
the regulation of the actin cytoskeleton, diacylglycerol signalling and the activation of the
ERK signalling cascade. The data presented within this thesis indicate that these events
may not be separate, but represent a co-ordinated cellular response to receptor activation.
Activation of Src stimulates the formation of lamellipodia, which in turn leads to the
activation of FAK. Src is then recruited into a complex with FAK and phosphorylates it
on tyrosine residues to allow the binding of Grb2/Sos, which initiates the activation of
ERK (Schlaepfer et al, 1994).
Src was also found to be involved in the activation of DGK^, which phosphorylates
diacylglycerol to produce phosphatidic acid. This provides a potential mechanism for the
feedback regulation of conventional and novel PKC isozymes, which are allosterically
activated by diacylglycerol. In addition, Raf-1 has been shown to be recruited to the
plasma membrane by binding to phosphatidic acid (Ghosh et al., 1996). Thus, DGK^
may also participate in the activation of ERK 1 and 2.
Phosphatidic acid is also known to be an important intermediate in the biosynthesis of
phosphatydlinositol and activates PBP-5 kinase, which phosphorylates PtdIns(4)P to
produce PtdIns(4,5)P2 (Toker, 1998). As well as serving as serving as a substrate for
PLC, PtdIns(4,5)P2 regulates the activity of many proteins involved in the regulation of
the actin cytoskeleton (Sechi and Wehland, 2000). Therefore, DGK^ may also be
involved in the regulation of the cytoskeleton in SCL60 cells.
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Overall these studies demonstrate the integrative nature of signal transduction in
eukaryotic cells, and that several pathways may interact to give a co-ordinated response
to a given signal.
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